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Zusammenfassung 
 
Die Amoebe Acanthamoeba castellanii gehört zu den frei lebenden Amoeben der 
Familie Acanthamoebidae und ist weltweit aus vielen verschiedenen Quellen zu 
isolieren. Wie alle Amoeben, leben auch diese räuberischen eukaryotischen 
Mikroorganismen von Bakterien, Algen und Hefen und sind auch in der Lage 
menschliche Zellen zu lysieren. A.castellanii ist sowohl als Auslöser von Krankheiten 
als auch Überträger von humanpathogenen Bakterien nicht zu unterschätzen, da 
besonders bei immunsupprimierten Menschen schwere Infektionen, teilweise mit 
sehr fatalen Verläufen, beobachtet werden können. Die Amoebe ruft schwere 
Infektionen der Augen (Acanthamoeben-Keratitis) des Gehirns (granulomatöse 
Acanthamoeben-Encephalitis) und auf Haut und in der Lunge hervor. Die 
Behandlung einer A. castellanii Infektion ist nicht immer einfach, da sich der Eukaryot 
einer Heilung durch Zystenbildung entziehen kann. Im Zystenstadium ist A. 
castellanii in der Lage, einer Vielzahl von Bioziden zu trotzen und auch für ihn sehr 
lebensunwirklichen Umweltbedingungen unbeschadet zu überstehen. Die danach 
aufflammenden Infektionen haben meist einen schwereren Verlauf und können bei 
geschwächten Personen auch zum Tod führen. 
Der molekularbiologische Mechanismus und auch die an En- und Exzystierung 
beteiligten Proteine sind noch weitgehend unerforscht. Der erste Teil dieser Arbeit 
beschäftigte sich mit der Isolierung der Proteine des Mikroorganismus in den 
verschiedenen Zelldifferenzierungsstadien während der En – und Exzystierung 
mittels 2D Gelelektrophorese (2D PAGE). Die nach der Elektrophorese erhaltenen 
Proteinspots wurden einem tryptischen in-Gel Verdau unterworfen und mit MALDI 
RTOF MS und MALDI RTOF MS/MS analysiert. Die Auswertung der PMFs (Peptide 
mass fingerprints) und PSD MS/MS Daten erfolgte mit der Proteindatenbank Mascot. 
Im zweiten Teil der Arbeit wurde eine neue nano high-performance chromatography 
(nHPLC)-Methode entwickelt um eine Vortrennung der manchmal aus mehreren 
Proteinen bestehenden Proben zu ermöglichen. Die aufgetrennten Proben wurden in 
verschiedenen Fraktionen auf ein MALDI Target gespottet und mit MALDI RTOF MS 
und MALDI RTOF MS/MS analysiert. Es konnten den Proteinspots „Enc 2“ das 
Protein „Actin“ und dem Spot „Alle 6“das Protein „Elongationsfaktor 2“ einwandfrei 
zugewiesen werden.  
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Abstract 
 
The amoeba Acanthamoeba castellanii belongs to the free living amoeba in the 
family of Acanthamoebidae, which can be isolated from a lot of sources all over the 
world. Like all other amoeba species this microorganism lives manly on bacteria, alge 
and yeast and is able to lyse human cells. A. castellanii is on the one hand elicitor of 
diseases and on the other hand carrier for humanpathogen bacteria which can cause 
harmful diseases that are very dangerous for immunsuppressed patients. The 
chances for immunsuppressed patients to get cured from such an infection are not 
high. A .castellanii causes infections in the eyes (acanthamoeba ceratitis) in the brain 
(amoeba encephalitis), also in the lungs and on the skin. A therapy of this kind of 
infection is not easy because the amoebas ability to form stable cysts. In its cyst 
stadium the amoeba can resist a lot of biocides so that medication can be ineffective. 
When the medication stops the infection starts again, but this time the infection 
becomes more serious and frequently life-threatening for immunsuppressed patients.  
The molecular mechanism and the proteins of the en and excystment are not 
identified yet. The aim of the first part of my thesis was to identify the proteins of A. 
castellanii during en- and excystment. The proteins were separated with 2D 
gelelectrophoresis (2D PAGE) and single protein “spots” were achieved. With these 
“spots” a tryptic digest was performed and the tryptic peptide mix was analysed by 
MALDI RTOF MS and MALDI RTOF MS/MS. The obtained PMFs (peptide mass 
fingerprints) and PSD MS/MS fragment data were evaluated by means of Mascot 
database search. 
In the second part of the thesis a protocol has to be developed for a nano high-
performance liquid chromatography spotter device (nHPLC-Spotter), to get better 
results and make it also possible to separate protein mixtures before the MALDI 
analysis. As a result the spot Enc 2 was identified as protein “actin” and the spot “Alle 
6” was identified as protein “ elongation factor 2”.  
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I. Introduction 
 
1. Biological background 
 
Amoebae are the most prevalent protozoa found in the environment. They are 
distributed worldwide and have been isolated from soil, dust, air, natural and treated 
water, seawater, swimming pool water, hospital surfaces, contact lenses and as a 
contamination in bacterial, yeast and mammalian cell cultures (1). All amoebae are 
single cell eukaryotic organisms belonging to the big group of protozoa. The life cycle 
of amoebae consist of two stages, an activated feeding stage (trophozoite stage) and 
a dormant cyst stage. The formation of cysts (encystment) occurs when the 
environmental conditions like pH or temperature change to the worse. The double 
walled wrinkled cyst consists of an ectocyst (first cyst wall) and an endocyst (inner 
cyst wall) and varies in size between 13-20 µm. Sizes varies from species to species. 
These cysts are resistant to biocides, chlorination and antibiotics and can survive 
over long periods at low temperatures (0°C to 2°C). When the environmental 
conditions become more suitable the degradation of the cyst initiated (excystment) 
resulting in an activated trophozoite amoeba. The active amoeboid cell is 
characterised by a central less viscous portion of the cytoplasm (endoplasm) and an 
outer portion of a continuous phase of cytoplasm (ectoplasm) and the formation of 
pseudopodia, used for their movement. This amoeboid kind of movement is a general 
characteristic of all amoebae (1).  
 
All amoebae are heterotrophic, they feed on bacteria, algae and yeasts in the 
environment, but can also take up small nutrical particles by pinocytosis and some 
pathogenic strains can also lyse human cells. Digestion in the free living species is 
normally done by hydrolases. Entamoeba histolytica as a member of pathogenic 
intestinal amoebae, ferments carbohydrates producing thereby ethanol and CO2. The 
waste removal in all amoebae species is done by pulsing vacuoles which can fuse 
with the outer membrane. Reproduction is taking place during the trophozoite state 
by mitosis. 
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The large group of amoebae is a very heterogenous group. It is now generally 
accepted that the amoebae belong to different phylogenetic groups and do not 
represent a monophylum. 
Acanthamoeba was first described by Castellani in 1930. He found amoeba in his 
fungi cell cultures and named it Hartmannella (2). A year later Volkonsky subdivided 
the genus Hartmannella in 3 genera classified by cyst formation and cyst appearance 
(3).Sawyer & Griffin finally established the family Acanthamoebidae in 1975 (4). The 
currently accepted taxonomy of Acanthamoeba and other free living amoebas is 
shown in figure 1.         A    B 
 
Figure 1. The scheme of free living amoebae (Light microscopic image of column A: 
trophozoite states and column B: cyst states) (1) 
 
Modern molecular genetic studies confirm the classification done by Pussard & Pons 
in 1977 which is based on the comparison of morphological appearances of cysts in 
free living amoebas. Pussard & Pons subdivided the different species of 
Acanthamoeba to 3 cyst morphological groups (6). 
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Group 1 Group 2 Group 3 
A. astronyxis 
A. comandoni 
A. tubiashi 
A. castellanii 
A. divionensis 
A. griffin 
A. hatchetti 
A. lugdunensis 
A. mauritaniensis 
A. polyphaga 
A. quina 
A. rhysodes 
A. triangularis 
A. culbertsoni 
A. lenticulata 
A. royreba 
A. palestinensis 
Table 1. Groups of Acanthamoebas (6) 
 
The species belonging to group 1 form relatively big trophozoites and cysts with 
diameters over 18 µm. The smooth endocyst and the star shaped ectocyst are clearly 
separated (Figure 2a).Acanthamoeba castellanii belongs to the Group 2 of 
Acanthamoebae characterised by a diameter of less than 18 µm. The ectocyst can 
be thick or thin but it is clearly separated from the endocyst. The shape of the 
endocyst can vary from star shape over triangular to round (figure 2b). The cysts of 
the Acanthamoeba species belonging to Group 3 have diameters under 18 µm and 
their exo- and endocyst are round and closely together (figure 2c). 
 
 
Figure 2a-c. Light microscopic image of cysts of Acanthamoeba Gr. 1 (a), Gr. 2 (b), 
Gr. 3 (c) (5) 
 
 
10  
 
Another very important classification of Acanthamoeba was established by Gast et al. 
(6) in 1996. He developed a classification schema based on nuclear r RNA gene 
sequences (18rDNA). The complete gene sequence of nuclear small ribosomal 
subunit RNA (Rns) was determined. Using this approach Stothard et al. (7) classified 
53 isolates of Acanthamoeba species on the basis of 12rDNA sequence types (Rns 
genotypes) designated typing units T1 to T12. Current classification schemes 
integrate the morphological groups which were established by Pussard and Pons (6) 
with the 12 sequence types (Rns genotypes) such that Group 1 includes sequence 
types of T7, T8 and T9 ,Group 2 includes sequence types T3, T4 and T11, and 
Group 3 includes sequence types T1, T2, T5, T6, T10 and T12. The majority of 
Acanthamoeba castellanii clinical isolates which has been analysed belonging to 
sequence type T4.  
 
The trophozoites of Acanthamoeba are normally flat and without any typical shape 
(figure 3a-c). Their size is between 15-45 µm and the cell surface is covered with 
long spiny protectors made of hyaline called acanthopodia. The same organelles 
found in Acanthamoeba were also found in other higher eukaryotic cells like Golgi 
complex, smooth and rough endoplasmatic reticula, free ribosomes, mitochondria, 
digestive vacuoles and microtubules.  
 
Figure 3 a-c. Light microscopic image of trophozoites of free living Acanthamoeba 
(5) 
 
2. Medical Relevance 
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In the past years Acanthamoeba became of special interest for human medicine due 
to fact that Acanthamoeba cysts are very robust. They not only survive drug 
treatments, but also survive treatments with disinfectants. Moreover, amoebas are 
able to intracellular protect bacteria in their cysts. Especially, for people with 
suppressed immunsystems, resulting e.g. from special medical treatment, 
Acanthamoeba infections are very serious. They can cause illnesses like 
Granulomatous Acanthamoeba Encephalitis (GAE), Acanthamoeba keratitis and 
infections of lungs and skin. Special interest has been drawn on Acanthamoeba 
keratitis which is common under contact lens users all over the world. This small 
amoeba lives in the contact lenses fluid and can infect the cornea through micro 
lesions. The infection is very painful and needs a very long complicated treatment. 
GAE is a chronical or sub-acute processing illness of the brain with an incubation 
time from a few weeks to a few months normally ending with the death of the affected 
patient. Several pathogens of the genus Acanthamoeba were found in 
immunosuppressed patients. The affected individuals infect themselves by inhaling 
the cysts or getting into contact with contaminated water. They start to replicate in the 
human body and the cysts can be carried with the bloodstream and are able to finally 
cross the blood brain barrier. In the brain the amoebae start to lyse the cells and 
cause damage of large parts of the tissue. Normally, the treatment of this kind of 
infection is not successful even when the illness is recognised in its early state (8-11). 
 
3. Proteomics 
 
3.1. Protein 
 
In 1940 it was well known that proteins were built up by amino acids but it was not 
possible to determinate the sequences of peptides. In 1955, Sanger was able to 
identify the whole amino acid sequence of Insulin (12). In the beginning of 1950 a 
Swedish scientist Pehr Edman developed a more efficient way of amino acid 
determination known as Edman degradation which is still used nowadays (13). The 
information about the sequence of protein becomes more and more important in the 
field of biochemistry.Proteins are made of amino acids, molecule that contains both 
amine and carboxyl functional groups. Twenty common amino acids are used by 
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cells in protein biosynthesis specified by the general genetic code. All organisms 
differ in the amino acids they can synthesize and the ones they have to obtain 
through their nutrition. Those amino acids that cannot be synthesized by an organism 
are called essential amino acids. Amino acids are the basic structural building units of 
proteins. They are linked by an amide bond, also called peptide bond, to build up 
proteins. The sequence in which the amino acids are arranged is called primary 
structure of a protein. But just the correct folding into repeating local, (secondary 
structure), and a protein specific global (tertiary) structure, enables biological activity. 
The interaction of more than one protein subunit (quaternary structure) guarantees its 
full function. If proteins are treated with heat or chemicals they lose their native 
quaternary structure and as a consequence their biological functions as very often 
active centers are destroyed. This so called denaturation is in many cases 
irreversible so it is not possible to reconstitute the protein. This can be explained by 
the different characteristics of the functional side chains of the amino acid. The side 
chains are the variable part of an amino acid and are the reason for the differences in 
size, chemical reactivity, charge and molecular weight (Table 2) (14,15). 
 
Table 2. Overview over the 20 most common amino acids (15) 
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Amino acids are molecules that contain both an acidic group and a basic group, and 
are therefore ampholytic, which means that they are chemically neutral but have 
formal positive and negative charge on different atoms. A mixture of ampholytic 
substances can develop a pH gradient in an electric field and when amino acids were 
added they start to move to their specific isoelectric point (pI). The pI is the point 
where the netto charge of the amino acid is zero. This specific nature of amino acids 
and proteins is used in the first step of 2D electrophoresis (isoelectric focusing) one 
of the most important methods in protein analytics nowadays. 
 
3.2. Proteome 
 
The first very important invention for the research field of proteomics was published 
in 1975 from O´Farrel (23) and Klose (24). They made it possible to separate 
complex mixtures of proteins using a combination of isoelectric focusing (IEF) and 
SDS gel electrophoresis. This new method, the 2D gel electrophoresis, started to 
become one of the most important methods in biochemistry. This new method has 
the advantage to be a separation technique with a high resolution. At the time most 
of the analytical methods for protein characterisation (sequence analysis, amino acid 
sequencing) were not able to analyse small amounts of protein coming from the 2D 
electrophoresis. Another reason was the fact that the proteins were imbedded in a 
gel matrix which was incompatible with the protein chemical techniques during this 
time. This problem changed after new developments in protein chemistry. A lot of 
methods were improved or become more sensitive, furthermore it was possible to 
cleave proteins in the gel matrix and to transfer it onto a chemically inert membrane 
and have the opportunity to analyse them.  
The biological vocabulary has been expanded with a series of “omes”: the genome 
(DNA sequence of an organism), the transcriptome (the messenger RNA expressed 
at a given time in the cell) and in 1995 Marc Wilkins (16) created the word proteome 
(the protein equivalence of a genome) as the study of proteins.  
In contrast to genomic analysis proteomics is much more complex because the 
genome of an organism is more or less constant; a proteome differs from cell to cell 
and during its biochemical interactions with the environment and other cells. Another 
very important difference is the complexity of proteins because of mechanisms such 
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as alternative splicing, protein modification (glycosylation, phosphorylation) and 
protein degradation. 
The identification and quantification of a complete set of proteins from organs or cells 
at any time requires powerful analytical techniques. Proteomics is a rapidly 
expanding field of research which requires sensitive and selective technologies.  
The following sets of techniques are commonly used in proteomic experiments.  
 
• Two dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
 
• Liquid high performance chromatography (HPLC)  
 
• Matrix assisted laser desorption/ionisation mass spectrometry (MALDI-MS)  
 
• Electrospray ionization mass spectrometry (ESI-MS) 
 
Over the years of research on the field of proteomics a lot of new technologies e.g. 
nanotechnology and methods e.g. protein microassays were established helping the 
scientists to identify proteins and protein interactions within different cells, organs and 
organisms (17). 
 
4. Tools for Proteomics  
 
4.1. Sample pre-treatment 
 
Most of the samples in protein chemistry are a mixture of more than one kind of bio 
molecule. In a lot of cases it is not possible to identify the proteins in this mixture 
because of contaminations, complexity of the mixture and other disturbing agents. In 
proteomics it is necessary to pretreat the sample either to get rid of contaminations to 
enrich the amount of protein or to fractionate the proteome. 
 
There are 5 commonly used sample preparation methods:  
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• Precipitation: For this fast and easy sample preparation mostly salts and 
organic solvents were used. A disadvantage of this method is the relatively 
high protein loss during purification. Therefore, this method cannot be used 
when protein concentrations are very low. It has turned out that the efficiency 
can be improved by freezing but this protocol should not be done with 
temperature sensitive proteins (26). 
 
• Ultrafiltration: This separation process is used to purify and concentrate 
protein solutions. The basic of ultrafiltration is membrane filtration; a solution is 
pressed against a semi permeable membrane by hydrostatic pressure forces. 
Molecules of high molecular weight will be retained while water and other 
small solutes pass through the membrane (26). 
 
• Dialysis: Dialysis is used for desalting and to change buffers. A semi 
permeable membrane, e.g. cellulose acetat or nitrocellulose, is placed 
between the sample solution and the exchange medium. Due to the osmotic 
pressure, the salts diffuse through the membrane, whereas proteins are 
retrained on one side (26). 
 
• Chromatographic methods are based on the distribution of the analyte 
between a mobile and a stationary phase. This principle of reversed phase 
liquid chromatography (RPLC) is used in ZipTip Technology (18) .These Zip 
Tips are polypropylene micropipette tips with an expanded bed of 15 µm silica 
particles. The particles can be modified with C4- or C18- alkyl residues and 
therefore this type of ZipTips can be compared to a micro reversed phase 
column. For various sample preparation questions other types of ZipTips are 
available e. g.: filled with metal chelat resin (IMAC) or strong cation resin 
(IEX). All of these materials allow a bi-directional flow and therefore easy 
handling is possible. The tip is soaked with protein solution and thereby the 
protein is bound to the silica particles. In the next step the protein is washed 
and then eluted with an organic solvent. Due to the easy handling ZipTips are 
commonly used for desalting, concentration and sample preparation before 
MALDI-MS. 
 
16  
 
4.2. Enzymatic protein cleavage 
 
In proteomics the complexity of native proteom has to be reduced to analyse them 
first by means of a protein separation technology (e.g. 2D PAGE).After the reduction 
of complexity specific enzymes were applied which cut the protein on specific 
cleavage sites. Every enzyme has its specific cleavage sites that are well known. 
There are 2 possibilities to digest a protein with an enzyme; first the digestion takes 
place in solution or second in a gel matrix.  
 
Some sample preparation steps have to be done before starting an enzymatic digest. 
At first the proteins have to be reduced and alkylated. In this step disulfide bonds are 
broken and the free generated cysteins are alkylated to avoid recombination. So the 
enzyme can reach all its target bonds. In a further crucial step all contaminates have 
to be eliminated e.g. alkylation reagents, to guarantee reaction conditions suitable for 
the enzyme as the enzyme itself might get reduced or alkylated. To establish perfect 
conditions for the enzymatic cleavage the solvent has to be exchanged by a 
convenient digestion buffer. After adding the enzyme the enzymatic cleavage is 
carried out under “enzyme-friendly” conditions (correct pH, optimum temperature).  
After successful digestion the peptides can be washed out of the gel matrix and after 
additional washing steps, to remove unwanted buffer salts, peptides can be used for 
further analyses e.g. MALDI-MS or ESI-MS. 
 
Trypsin is the most commonly used enzyme for a lot of different analysis. Trypsin is 
an endoprotease; it hydrolyses peptide bonds C-terminal of lysine and arginine. 
Trypsin, a serine protease is found in the digestive system of many different species, 
including humans, but mostly bovine or pig trypsin is used for biochemical 
applications. It has its highest activity between pH from 7.5 to 9 and a temperature of 
37°C. In all experiments peptide digestion were carried out with a chemically 
modified Trypsin (This enzyme is chemically protected against self digestion). 
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4.3. Electrophoresis 
 
The first electrophoresis was conducted by the Swedish scientist called Arne Tiselius 
in 1926. He was able to separate the main constituents of the human serum albumin, 
α-, β- and γ-globulin and therefore was awarded the Nobel Prize in 1948 (19). In 
1959 Raymond and Weintraub invented polyacrylamide gels which are used for 
separation of DNA and protein mixtures by their different molecular weights (20). The 
next milestone in electrophoresis was the invention of agarose gels in 1961, which 
are used for analysis of DNA fragments (21).With the introduction of carrier 
ampholytes, which form stable pH gradients, in 1964 by a Swedish scientist, the 
separation of analytes by their different pIs (isoelectric focussing,[IEF]) became 
possible (22). Nevertheless electrophoresis had its breakthrough in 1975 when 
O´Farrell and Klose applied a new outstanding method called 2D electrophoresis (23, 
24). 2D electrophoresis is a combination of IEF and Sodium dodecyl sulphate 
Polyacrylamide gel electrophoresis (SDS-PAGE) and they were able to separate total 
cell lysates. Based on that they gained information on the proteome of a whole cell. 
In 1988 a further improvement of 2D electrophoresis immobilised pH gradient (IPG) 
was introduced (25). The advantages of 2D electrophoresis are its good 
reproducibility, high loading capacity and highest resolution achievable for protein 
mixtures. 
 
4.3.1. Principles of electrophoresis (26) 
 
Electrophoresis is based on the migration of charged particles in an electrical field. 
Because of their different charges and molecular weights the particles have different 
electrophoretic velocities during migration in the electrical field. 
 
Three types of electrophoresis are commonly known: 
 
• Zone electrophoresis, uses a homogenous buffer system, thus gel 
electrophoresis belongs to this group.  
• Isotachophoresis uses a discontinuous buffer system. 
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• Isoelectric focussing uses a pH gradient to separate the substances due to 
their pI values. 
 
Media for electrophoretic separations: 
 
• Solution, where separation is based on charge differences.  
• Stabilising matrix, like membranes or gels. In these matrices separation is 
based on charge and size of applied particles. 
 
 
4.3.2. Sample preparation 
 
All kind of electrophoretic methods are sensitive against high salt and buffer 
concentrations and therefore buffer concentration are limited to 50 mmol/L. To obtain 
this level of salt and buffer concentration, desalting steps are often necessary, like 
gel filtration, dialysis, precipitation ect. Complete dissolvation of the sample is 
necessary because small solid particles, lipid droplets or insoluble proteins may 
interrupt separation. To avoid this problem filtration or centrifugation of the sample 
are recommended. Nevertheless it can happen that some proteins are insoluble or 
are getting insoluble. For this kind of proteins special sample solvents are available. 
 
The sample for 2D gel electrophoresis has to be converted from its native form to a 
more suitable and stable conformation for IEF while preserving the native charge and 
molecular weight (Mr) of the protein of interest. Several sample preparation steps 
have to be done like solubilisation, disaggregation, denaturation and reduction of the 
sample (27). Complete denaturation has to be done to make sure that the protein is 
present in only one conformation and that no aggregation and intermolecular 
interactions will occur.  
 
4.3.3. Isoelectric Focusing (IEF) -1.Dimension  
 
IEF separates the proteins according to their isoelectric points (pI). On its pI the net 
charge of a protein and therefore the velocity in an electrical field is zero. The net 
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charge of a protein is the total of all formal positive and formal negative charges of 
the amino acid side chains and is influenced by the protein configuration and 
modifications like phosphorylation or glycosylation. There is also a focussing effect 
acting on the proteins which concentrates them at their pI values. This effect appears 
when the protein diffuses away from the pI, then it gains charge again and migrates 
back to the pI. 
 
Types of pH gradient: 
 
• Carrier ampholytes are small aliphatic molecules with different pI values. The 
advantage of the carrier ampholytes are high buffer capacities, high solubilities 
and constant conductivities near the pI. Its disadvantage is low reproducibility 
of separation as well as of producing the pH gradient, low stability of the 
gradient and tendency to drift towards the cathode. 
• Immobilised pH gradient (IPG): Immobilizes are derivatives of acryl amide and 
are weak acids or bases that are polymerised within a gel matrix. The 
advantages of IPGs are that they are stable throughout the separation, its high 
reproducibility and high loading capability. The disadvantages are the complex 
production of IPGs and the long separation times. 
 
Several types of sample application in IEF: 
 
• Rehydration loading: The sample is a component of the rehydration solution. 
Advantages of this method are application of lager sample quantities, no 
precipitation on the point of application and easy handling. 
• Cup loading: The sample is placed in so called sample cups. These cups 
should contact the gel to avoid leakage and should not destroy it. The 
application point on the IPG strip depends on the nature of the sample. 
Disadvantages are lower sample loads and the possibility of protein 
precipitation. 
• Paper-bridge loading: The paper-bridge is soaked with the sample solution 
and then placed onto the IPG strip. 
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4.3.4. SDS-PAGE – 2.Dimension 
 
In the second dimension SDS PAGE is used for separation. This separation is based 
on the different molecular weights of the proteins and peptides in a mixture. Before 
separating the proteins by mass, high concentrations of sodium dodecyl sulphate 
(SDS) has to be added to sample and buffers. SDS denatures the proteins and 
binds a number of SDS molecules roughly proportional to the protein's length. 
Because a protein's length (when unfolded) is roughly proportional to its mass, 
this is equivalent to saying that it attaches a number of SDS molecules roughly 
proportional to the protein's mass. Since the SDS molecules are negatively 
charged, the result of this is that all of the proteins will have approximately the 
same mass-to-charge ratio as each other. In addition, proteins will not migrate 
when they have no charge therefore the coating of the protein in SDS allows 
migration of the proteins in the second dimension  
 
4.3.5. Gels for electrophoresis 
 
• Polyacrylamide gels (PA): PA gels are made of acryl amide monomers and 
polyacrylamide. After adding ammonium persulfate and 
Tetramethylethylenediamine (TEMED) the polymerisation of polyacrylamide 
and the acryl amide monomers starts leading to a stable, transparent and 
chemically inert gel matrix. 
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Figure 4. Chemical reaction, which builds up polyacrylamide. 
 
• Agarose gels: are made of Agarose, a polysaccharide extracted from sea weed. 
These kinds of gels are widely used in biosciences nowadays, because of their 
easy handling practice and their relatively wide application area. 
 
 
Figure 5. Chemical structure of the disaccharide, which is the basic unit of agarose. 
 
4.3.6. Visualisation of the proteins on the gel 
 
Detection of the protein bands can be done immediately on the gel. 
• Coomassie (triphenylmethane dye) G and R staining: A common visualisation 
method is the staining with Coomassie G and R, both with high affinity to the 
protein, high extinction coefficients and good detection limits (~ 1 µg) (28). The 
gels are soaked in dye, the dye is absorbed by the protein and excess stain 
is then washed away with a solvent ("destaining").  
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Figure 6.Chemical structure of Coomassie Brilliant Blue G 250 
 
• Silver staining: This kind of staining is important especially to show small 
amounts of proteins and glycoproteins on a gel. This staining protocol is more 
sensitive than Coomassie staining and allows visualization of proteins below 
1ng. The basic mechanism underlaying silver staining of proteins in the binding 
of silver ions to the amino acid side chains, primary the sulfhydril and carboxyl 
groups of proteins followed by reduction to free metallic silver. The protein bands 
are visualized as brown to black spots. (29) 
 
5. High Performance Liquid Chromatography (HPLC) 
 
5.1. Introduction 
 
Prior to the 1970's, few reliable chromatographic methods were commercially 
available to the laboratory scientist. This situation changed during 1970's were most 
chemical separations were carried out using a variety of techniques including open-
column chromatography, paper chromatography, and thin-layer chromatography. A 
lot of these chromatographic techniques were inadequate for quantification of 
compounds and similar compounds. These methods were very time consuming so 
that high pressure liquid chromatography was used to decrease experimental time. 
Liquid chromatography was able to reduce the separation time of a compound 
leading to the wide application of HPLC in the mid 1970´s (30). Not only the 
chromatographic technique was improved but a lot of new improvements in the fields 
of column packing materials, on-line detectors and new sample preparation 
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techniques prior to the separation made HPLC become one of the most important 
bioanalytical instruments. In the next years a lot of stationary phases like reverse 
phase liquid chromatography were improved helping to make the HPLC more useful 
in more and more analytical fields (31). 
Nowadays, HPLC is widely used and is a main technique for biotechnological and 
biomedical research and is regularly used in the pharmaceutical industry (32). 
 
The main parts of a modern HPLC system are: (schema is seen in figure 7) 
 
Figure 7. Schema of an HPLC System (www.upchurch.com/TechInfo/) 
 
5.2. Solvents (mobile phase) reservoir 
 
The reservoirs are containing the solvents that are continuously applied to the 
stationary phase in a column. The solvents are called mobile phase and are the 
carrier of the sample through the HPLC system. The chemical interaction of mobile 
phase and sample, with the stationary phase the migration behavior and final 
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separation of components contained in the sample. A change in the mixture of the 
mobile phase can lead to a change in the interactions of the sample with the 
stationary phase. There are two kinds of elution techniques: Isocratic and gradient 
elution.  
Isocratic elution: This is the most common elution technique in HPLC; a mobile 
phase of a fixed composition is used during the whole experiment.  
Gradient elution: The composition of the solvent changes during the whole 
experiment leading to better separation than isocratic elution. Normally, the sample 
is injected while a mobile phase with water content (polar solvent) is being applied 
to the system. The mixture of the mobile phase is changed stepwise or linear raising 
the organic solvent fraction resulting in elution of retained components (33).  
 
5.3. Pumps 
Pumps for use with HPLC analysis have to fulfill the following requirements: 
• Be able to create pressures up to 15 MPa 
• Chemical resistance 
• Constant delivery rate 
 
There are several types of pumps available:  
• Reciprocating Piston Pumps consist of a small motor driven piston which 
moves rapidly back and forth in a hydraulic chamber that may vary from 35-
400 µL in volume. On the back stroke, the separation column valve is closed, 
and the piston pulls in solvent from the mobile phase reservoir. On the forward 
stroke, the pump pushes solvent out to the column from the reservoir. A wide 
range of flow rates can be attained by altering the piston stroke volume during 
each cycle, or by altering the stroke frequency. Dual and triple head pumps 
consist of identical piston-chamber units which operate at 180 or 120 degrees 
out of phase. This type of pump system is significantly smoother than other 
types of pumps because one pump is filling while the other is in the delivery 
cycle.  
• Syringe Type Pumps are most suitable for small bore columns because this 
pump delivers only a finite volume of mobile phase before it has to be refilled. 
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These pumps have a volume between 250 to 500 mL. The pump operates by 
a motorized lead screw that delivers mobile phase to the column at a constant 
rate. The rate of solvent delivery is controlled by changing the voltage on the 
motor.  
• In Constant Pressure Pumps the mobile phase is driven through the column 
with the use of pressure from a gas cylinder. A low-pressure gas source is 
needed to generate high liquid pressures. The valving arrangement allows the 
rapid refill of the solvent chamber whose capacity is about 70 mL. In contrast 
to the other pumps these kinds of pumps have low level of pulsations which 
provides continuous mobile phase flow rates. 
 
5.4. Injection port 
 
Samples are injected into the HPLC via an injection port. The injection port of an 
HPLC commonly consists of an injection valve and the sample loop. The sample is 
typically dissolved in the mobile phase before injection into the sample loop. The 
sample is then drawn into a syringe and injected into the loop via the injection valve. 
A rotation of the valve rotor closes the valve and opens the loop in order to inject 
the sample into the stream of the mobile phase. Loop volumes can range between 1 
µl to over 500 µl (34). 
 
5.5. Columns 
 
Nowadays, in bioscience most of the HPLC analysis uses the reversed phase 
method (reversed phase HPLC). In RP-HPLC the stationary phase consists of an 
unpolar material and the mobile phase is made of a polar solvent (reversed phase). 
The typical column for RP-HPLC is made of stainless steel or fused silica filled with 
small sized particles made of modified silica gel or polymer material (stationary 
phase). The inner diameter of a typical column ranges from 3-5 mm whereas the 
internal diameter of a typical capillary column ranges from 3 to 200 µm. The particle 
size of the packing material ranges from 3-10 µm in standard columns and from 2-5 
µm in capillary columns. In most of the HPLC systems precolumns are used to 
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purify the sample from unwanted contaminations and to protect the analytical 
column to extend the lifetime of the column. This precolumns are normally much 
shorter, have larger inner diameters and higher particle sizes than the standard 
columns.  
 
5.6. Detectors  
 
The detector for an HPLC is the component that generates a response due to the 
eluting sample compound and subsequently forms a peak in the chromatogram. It is 
positioned immediately posterior to the column in order to detect the compounds as 
they elute from the column. The width and height of the peaks may usually vary 
significantly, and the detection as well as sensitivity parameters have to be adopted. 
There are many types of online-detectors that can be used with HPLC. Some of the 
more common detectors include: Ultra-Violet (UV), Fluorescence and Mass 
Spectrometry (MS). 
 
5.7. Nano HPLC (35-37) 
 
Miniaturisation of an HPLC-system implies that all system components should be 
downscaled, including column, connecting tubing, injector and detector or detection 
interface. LC columns of 75 µm inner diameter or less require flow rates of 200nL 
/min or less. To reach the very high sensitivity often required in proteomics analysis, 
it is necessary to deliver a stable and reproducible flow at rates at which miniaturised 
electrospray interfaces perform best. Flow splitting systems, in which the flow is split 
between the pump and the injector, are often used but have the disadvantage that 
high losses of sample can occur. A better solution is the use of dual syringe pumps 
that can generate low flow gradients and accommodate high back pressures. As the 
flow is not split with this technique, solvent consumption is very low, allowing for 
continuous automated analysis even if the syringes can only contain a limited 
volume. Exponential and sigmoidal gradients can be generated using two syringe 
pumps, a relatively large mixing chamber and two 4 port valves. Miniaturised LC 
systems can only accommodate nL to µL injection volumes. However, sensitivity is 
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proportional to the absolute amount of sample loaded on to the column. Therefore, a 
lower injection volume results in diminished sensitivity and thus in a higher limit of 
detection. 
 
6. Mass Spectrometry  
 
Mass spectrometry is an analytical technique to determine the m/z values of ions 
present in a high vacuum. A mass spectrometer consists of an ion source to produce 
ions, a mass analyser to separate the ions due to their different m/z ratio and a 
detector to detect and quantify the ions. 
Matrix assisted laser desorption/ionisation (MALDI) and electrospray ionisation (ESI) 
are the most commonly used desorption/ionisation techniques in bioscience 
nowadays, mostly because high and polar molecular substances can be 
desorbed/ionised, in a very gentle way, leading to very low fragmentation and 
unproblematic molecular weight determination. ESI is commonly coupled with 
quadrupole or ion-trap analyzers, whereas MALDI-MS is mostly coupled with time of 
flight (TOF) analyzers. 
 
6.1. Matrix assisted laser desorption/ionisation – 
mass spectrometry (MALDI-MS) 
 
6.1.1. Introduction 
 
To reach direct desorption and ionisation of organic molecules out of condensed 
phases lasers were already applied in the 1970s. Therefore thin sample layers were 
applied on a metallic surface and then irradiated with pulsed laser beams. Mass 
spectra with low peak intensity and high sample fragmentation were the result. Only 
ions with low molecular masses up to 2 kDa could be detected, that was the reason 
why laser desorption/ionisation mass spectrometry had very low importance for 
analyses of biomolecules. 
In 1987 Karas, Hillenkamp and Tanaka (Nobel Prize 2002) invented MALDI-MS (38-
40). With a new sample preparation method they were able to produce mass spectra 
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with higher peak intensity and hardly any fragmentation. The sample molecules were 
embedded into a solid/liquid matrix. These matrices were small organic molecules 
with high absorption at the laser’s wave-length. UV absorbing matrices are used for 
UV laser, like N2-laser (337 nm) and Nd:YAG-laser (355 or 266 nm), whereas IR 
absorbing matrices are used for IR lasers, like Er:YAG-laser (2,94 µm) and CO2-laser 
(10 µm).  
 
6.1.2. MALDI matrices 
 
 
Figure 10. Chemical structures of commonly used MALDI matrices for UV lasers. 
 
The most important properties for a MALDI matrix to fulfil: 
 
• Absorption of the laser light with a particular emitted wave-length of the laser 
• Isolation of the molecules via a solid crystalline or liquid viscous matrix 
• Assembly of the analyte into the crystal lattice, so no intermolecular 
interactions can occur 
• Providing support for ionisation (e.g. proton –transfer, adduct formation) 
 
6.1.3. Sample preparation 
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The crucial point of MALDI-MS is the sample preparation. There are two important 
requirements to the sample. When measuring low concentrated samples the ion 
currents may reach the limit of detection and samples with higher concentrations may 
result in saturation of the detector and this causes broad, not useful signals. High 
sample concentration often leads to decreasing peak intensities and low resolution 
due to peak broadening. The standard sample amount actually needed is in the 
range of pico mol and femto mol.  
The second request is high purity, because high concentrations of salt, buffer and 
detergents can interfere with the co-crystallisation of analyte and matrix. Additionally 
these contaminants are also visible in the mass spectra, because they are easy to 
desorb and ionise or are already charged. A crucial point is that the liquid containing 
the matrix and the liquid containing the sample have to be mixable. 
 
There are four different main types of sample preparation (41): 
 
• Dried-droplet method: 0,5-2 µL sample and 0,5-1 µL matrix solution are mixed 
on the MALDI target and allowed to air-dry.  
• Volume method: When using the method mentioned above sample and matrix 
solution are mixed directly on the target. When using the volume method 
sample and matrix solutions are pre-mixed in an Eppendorf tube and then 1-
1,5 µL of the mixture are applied on the target and dried under a gentle stream 
of air. 
• Thin-layer method: A thin homogeneous layer of small matrix crystals is 
produced by applying 0,5 µL matrix solution whereas the solvent is a fast 
evaporating solvent on the target. The droplet is allowed to dry. Then 0,5-1 µL 
sample solution is applied on the matrix layer and the spot was dried under a 
gentle stream of air. 
• Sandwich method: The first step of this method is analogous to the thin-layer 
method, a thin homogeneous matrix-layer is applied on the target and on this 
layer the sample is applied and allowed to air-dry. An additionally layer of 
matrix is applied on top of the already dried spot and dried under a gentle 
stream of air. 
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6.1.4. Laser 
 
As the mostly used MALDI instruments are equipped with an UV-laser, the following 
chapter deals primarily with the UV-laser. The laser beam spot with a diameter of 
about 150 µm for UV lasers is focused over an optical system onto the sample plate. 
Commonly used laser intensities are 106 to 107 W/cm2, if higher intensities are used 
this can result in fragmentation of the analyte. 
Wavelength and laser pulse duration are dependent on the type of laser. The 
standard N2-laser has a pulse duration of 3-5 ns and a wavelength of 337 nm 
whereas the pulse of a Nd:YAG-laser lasts 5-15 ns and works with 355 or 266 nm.  
 
6.1.5. The Desorption/Ionisation Processes in UV-
MALDI 
 
 
Figure 11. Principle of MALDI process 
 
Until now the mechanisms of MALDI desorption/ionisation process is not completely 
understood.  
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Proposed mechanisms for primary desorption/ionisation (42): 
 
• Multiphoton ionisation: A good explanation for ion generation with laser 
excitation is the ionisation of an absorbing organic molecule by more than one 
photon (M+°). 
 
M → M+° + e- 
 
For a long time this process was considered to be the key to all other MALDI 
ions. These directly excited matrix molecules (M*) have a few nanoseconds 
lasting life time, but nevertheless another photon could be absorbed to create 
the matrix radical cation. 
 
M → M* → M+° + e- 
 
This two photon process is very unlikely due to the usually used laser 
intensities.  
 
• Energy pooling and multicenter models: Another possibility to generate matrix 
radical cations or highly excited matrix molecules is that two or more 
separately excited matrix molecules (M*M*) pool their energy.  
 
MM → M*M* → M + M+° + e- 
 
M*M* + A → MM + A+° + e- 
 
• It is statistically more likely that a neighbouring molecule of an excited 
molecule absorbs a photon rather than that the already excited molecule will 
be hit by a second photon. Thus the energy pooling mechanism will be 
favoured, if it can occur.  
 
• Disproportionation reactions: It is a fact that some matrices will often perform 
ionisation in positive and as well in negative ion modes. A good correlation to 
this phenomenon gives the disproportionation reaction model.  
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2M → (MM)* → (M – H)- + MH+ 
 
• Excited-state proton transfer (ESPT): ESPT is a very common ionisation 
model. It requires only one photon for ionisation. A singly excited matrix 
molecule is assumed to become more acidic than one being in the ground 
state. Thus neighbouring analyte or matrix molecules become protonated and 
the excited matrix molecule relaxes.  
 
M + hv → M* 
 
M* + A → (M – H)- + AH 
 
M* + M → (M – H)+ + MH 
 
Proposed mechanisms for secondary ionisation (42): 
 
• MALDI plume: Due to molecular dynamics simulations the UV-MALDI plume 
can be described as a very rapid solid to gas phase transition where single 
molecules, clusters and matrix aggregates are ejected. To minimize the 
generation of these clusters the laser intensity has to be kept at the threshold 
of ion generation. The maximum amount of free molecules and small clusters 
can be reached at intensities close to the threshold for ion production.  
 
• Gas phase proton transfer: The possibility that many matrix-matrix reactions in 
the plume can occur is obvious. Primary ions normally are radical cations, 
whereas proton transfer can lead to protonated matrix ions. 
 
M+° + M → MH+ + (M – H)° 
 
Whereas protons are mobile in hydrogen-bonded networks, like water, they 
are less mobile in matrix clusters, but still mobile enough to migrate over some 
distance to be trapped by an analyte with higher proton affinity, such as 
peptides and proteins.  
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• Gas phase cationisation: Cationized molecules are mainly generated through 
ion-molecule reactions in gas phase, like several studies have documented.  
 
6.2. MALDI-TOF-MS 
 
6.2.1. Reflectron-TOF 
 
Figure 12. Schematic construction of a reflectron time of flight mass analyser 
 
Due to the desorption/ionisation process the ions are already moving and therefore 
possess different velocities before acceleration takes place. This results in energy 
and spacial spreading, different velocities of the ions, different flight times and finally 
in peak broadening at the detector. One solution for this problem is using a reflectron-
TOF analyzer. It possesses an ion reflector, which possesses an electric potential 
gradient and is called “reflectron”. The ions are decelerated in the reflectron and 
passes a turning point of their flight path at different locations in the reflector. So ions 
with higher kinetic energy spend a longer time in the mirror as ions with lower kinetic 
energy. When the geometry and voltages of the reflectron are optimised, the 
spreading of the arrival times can be corrected which leads to an increased mass 
spectrometric resolution (43). 
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6.2.2. Time delayed extraction 
 
This method is used with a time-of-flight mass spectrometer in which the accelerating 
voltage pulse is applied after a time delay following pulsed desorption ionization from 
a surface. The extraction delay can produce energy focusing and improve mass 
resolution and prevent peak broadening. 
 
6.3. Detector 
The detector used in MALDI TOF MS is a channel electron-multiplier Array (CEMA) 
which consists of a honeycomb arrangement of many channels, each having a 
diameter on the order of 25 µm. The internal surface of each channel is coated with a 
resistive conductor much like that of the nonmagnetic electron multiplier. A potential 
difference applied to opposite ends of the channels cause a gradient along the 
resistive conducting surface (44). 
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II. Materials and Methods  
 
1. Chemicals 
 
Acetone (p.a.), acetonitrile (p.a.), acidic acid (glacial, anhydrous; 100%), formic acid 
(98-100 %), and methanol (p.a.) were obtained from Merck (Darmstadt, Germany). 
ACTH (fragment 18-39), angiotensin II, bradykinin (fragment 1-7), N-acetyl renin 
substrate, 1, 4 dithioerythriol (DTT; min 99, 0 %), iodoacetamide (IAA; min 99%), 
ammoniumhydrogencarbonate (NH4HCO3  p.A.) and α-cyano 4-hydroxy cinnamic 
acid (min 99%,CHCA) and trifluoroacetic acid (TFA) were obtained from Sigma-
Aldrich (Steinheim, Germany) 
Ultra pure H2O (UHQ) was prepared from distillate H2O using Simplicity® Millipore 
system (Ωm ≤ 18µS/cm) 
Trypsin (modified sequence grade) was obtained from Roche (Basel, Switzerland) 
 
2. 2D gel electrophoresis 
 
The 2D gel electrophoresis was prepared by Dr. David Leitsch during his Ph.D thesis 
(1) at the Clinical Institute for Hygiene and Medical Microbiology, Medical University 
Vienna. 
 
2.1. Sample preparation  
 
After cell-harvest (600 g), pellets were always washed once in 1xPBS followed by 
another washing step in UHQ to remove residual serum proteins from the culture 
medium (and salts from 1x PBS). When studying whole cell lysates, disruption of 
cells is not a critical step, as the 2DE solubilisation buffer thoroughly and quickly 
lyses A.castellanii trophozoites. However, repeated freezing and thawing or 
disruption in a Dounce homogenizer can be applied if deemed necessary. Because it 
is important to keep salt concentrations as low as possible, due to the fact that salts 
interfere with isoelectric focussing (IEF), the pellets are normally resuspended in an 
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appropriate volume of UHQ. After that a solution of 12.5% tetrachloroacetic acid 
(TCA) in acetone (-20°C) was added until a TCA concentration of 10% was attained. 
Proteins were precipitated at -20°C for at least one hour. Afterwards, the precipitated 
proteins were centrifuged at 20,000 g for 20 min (4°C) and washed twice with icecold 
90% acetone/ 10% UHQ (v/v). These washing steps are essential because residual 
TCA would severely disturb IEF. After washing, pellets were air-dried for 30 minutes 
and resuspended in an appropriate amount of 2DE solubilisation buffer (7M urea, 2M 
thiourea, 1% DTT, 1% ampholytes, 4% 3[(3-Cholamidopropyl)dimethylammonio]-
propanesulfonic acid (CHAPS)). Resolubilization should be given enough time (2h or 
more) under mild shaking, e.g. in a thermo-mixer. However, temperature must not 
rise above 32°C, as the high urea concentrations might otherwise lead to 
carbamylation of proteins. After resolubilization 1h centrifugation at 100,000 g is 
recommended to remove residual nucleic acids or cell debris. More details are 
available from the PH.D thesis of David Leitsch (1). 
 
2.2. Isoelectric focusing 
 
The IEF was performed on a Tube Cell 175 together with a 1000/500 Power Supply 
(both devices from Biorad, Munich) 
 
The applied program for IEF consisted of following steps: 
 
 
1. Rehydration 12h (50 mV) 
2. 250 V, 1h, rapid slope 
3. 500 V, 1h, rapid slope 
4. 2000 V, 2h, linear slope 
5. 5000 V, 2h, linear slope 
6. 10000 V, 5h, rapid slope  
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2.3. Dimension SDS-PAGE 
 
It is essential that the pH of the resolution buffer (1.5 M Tris.HCl) is adjusted to pH 
8.6 as carefully as possible. If the pH is higher, protein spots tend to diffuse during 
2D-PAGE; lower pH intolerably slows down 2D-PAGE due to the elevated salt 
concentrations (pH is adjusted with hydrochloric acid). The agarose overlay-solution 
should be made with proteinase-free agarose, otherwise in-gel digestion of proteins 
can occur. The gels were run at 4°C at a constant current of 20 mA. 
 
2.4. Visualization 
Visualization by Coomassie Blue Brilliant was done after following protocol: 
The gel was fixed for 30 minutes in fixing solution (45 % MeOH, 5 % acetic acid, 
UHQ). In the second step the gel was stained for 1 hour (or shorter when the spots 
are visible earlier) with staining solution (0,1 % Coomassie R 250, 45 % MeOH, 5 % 
acetic acid, UHQ). Destaining was done with solution 1 (40 % MeOH, 7 % acetic 
acid, UHQ) and 2 (5 % MeOH, 7 % acetic acid, UHQ) till the background appears 
transparent. More details are available from the PH.D thesis of David Leitsch (1). 
 
The spots of interest were cut out of the 2D gel and stored at -80°C.  
 
3. Tryptic in-gel digestion 
 
The gel spots were cut into small cubes and put into 0,5 µl Eppendorf tubes and 
washed two times with UHQ and UHQ/ acetonitrilie (1:1, v/v) for 15 min each. After 
the washing step the liquid is removed and the gel pieces were covered with 
acetonitrilie (ACN) for a few minutes and after the pieces are shrunk the ACN was 
removed and the gel was rehydrate in 50 mM ammoniumbicarbonate buffer 
(NH4HCO3) for 5 min. An equal volume of ACN was added to the Eppendorf tube and 
slightly mixed and incubated for 15 min at room temperature (RT). After the 
incubation all the liquid was removed and the gel pieces were dried in the vacuum 
centrifuge. After that the gels were swollen with 10 mM DTT (15,4 mg DTT in 1 mL 
50 mM NH4HCO3) and incubated for 45 min at 56°C on the Thermo mixer. The tube 
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was chilled to RT and all liquid was again removed from the gel pieces. After adding 
55 mM iodoacetamide solution (10,2 mg iodoacetamide in 1 mL NH4HCO3) the tube 
was slightly mixed and incubated for 30 min at RT in the dark. This procedure is 
followed by another washing step with 50 mM NH4HCO3 and ACN (1:1, v/v) and an 
incubation of another 20 minutes. The gel pieces were dried again in the vacuum 
centrifuge and afterwards rehydrated in digestion buffer .The digestion buffer consists 
of 12,5 ng trypsin/µl prepared in 50µl 50 mM NH4HCO3 .To be sure that the gel 
pieces will not dry during digestion the pieces were covered with a small volume of 
50 mM NH4HCO3. The digestion was performed over night at 37°C on the Thermo 
mixer. On the next day ACN was added to the tube and incubated for 15 min. The 
supernatant was transferred to a new 0,5ml Eppendorf tube and the remaining gel 
pieces were covered with a mixture of 0,1 % TFA and ACN (1:1,v/v). This procedure 
was repeated twice and followed by a final extraction step with ACN. The 
supernatants from all extraction steps were pooled. In the end the gel pieces were 
discarded and all the pools were lyophilised in the vacuum centrifuge. 
 
4. Desalting of protein mixtures 
 
The desalting of the sample was performed using Zip Tips (Millipore, Bedford, MA, 
USA). The sample is dissolved in 10 µL 0,1 % TFA prior to the desalting step. 
For all experiments C18 tips were used. 
The ZipTip was used according to the customer’s protocol, supplied by Millipore as 
follows: 
 
• The ZipTip was wetted three times with 10 µL wetting solution (0,1 % 
TFA/ACN (1:1,v/v)) 
• Further the bed was equilibrated three times with 10 µL equilibration solution 
(0,1 % TFA) 
• The tryptic peptides were bound to the chromatographic material by sucking in 
the solution three times 
• The bound peptides were washed three times with 10 µL wash solution (0,1 % 
TFA) 
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The peptides were eluted from the Zip Tip by sucking up 1.5 µl of a freshly prepared 
CHCA solution (3 mg/ml in 0,1%
contact with the target. The liquid was partly deposited on the target and removed 
again. This step was repeated twice and finally the complete solution was deposited.
In the end the spots were dried in a gentle stream of air.
 
5. Nano HPLC/MS (offline LC
 
5.1. Sample preparation
Directly after digestion the samples were diluted in 5µl ACN/0,1%FA (1:1,v/v) and 
briefly sonificated. The samples were pipetted directly in a 96 well 
put on the cooler of the LC autosampler.
 
 
5.2. Instrumentation
 
The nano LC experiments were performed using a nano HPLC connected to a 
MALDI Spotter device (EASY
Denmark). Matrix was delivered by
 
Figure13. Easy-nLC Spotter 
 
 TFA/ACN (1:1,v/v)). Then the tip was brought onto 
 
-MALDI) 
 
microtiter plate and 
 
 
-nLC Spotter, Proxeon Biosystems, Odense M, 
 a syringe pump. 
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The chromatographic separations were performed using a Proxeon fused silica 
trapping column (filled with 5µm silica C18 particles, ID 0,75 µm, length 35 mm) and 
a Proxeon analytical column (filled with 3µm silica C18 particles ,ID 0,75 µm, length 
10 mm). 
 
5.2.1. Nano LC settings  
 
Injection volume: 2µl 
Solvent A: H2O + 0,1% FA (v/v) 
Solvent B: ACN + 0,1% FA (v/v) 
Solvent flow: 500nl/min 
 
• Gradient: 
 
Figure14. Gradient used in all the experiments 
 
5.2.2. MALDI-Spotter settings 
 
Matrix solution: CHCA in ACN/0,1 % TFA (1:1,v/v)  
Matrix flow rate: 0,8 µl/min  
Spot volume: 2,0 µl  
 
6. MALDI-TOF-MS 
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6.1. Sample preparation 
 
Sample preparation was performed on stainless steel MALDI targets by using the 
following preparation technique.  
 
• CHCA applied in thin-layer technique (2) 
0,5 µL CHCA (6 mg in 1 mL acetone) solution were applied on the target. The 
solution spread immediately and the acetone was evaporated in a few 
seconds. This resulted in a thin homogenous layer of small crystals.  
On top of this layer 1 µL of ZipTip desalted sample solution was applied and 
dried in a gentle stream of air.  
 
6.2. Instrumentation 
 
The mass spectra were recorded on an AXIMA-CFR+ (Shimadzu Biotech Kratos 
Analytical, Manchester, UK). The AXIMA-CFR+ was equipped with a pulsed nitrogen 
laser (λ = 337 nm, 4 ns pulse width), a curved field reflector, an integrated 1 GHz 
recorder and a monochrome CCD camera for monitoring the sample inside the 
instrument. 
All peptide mass fingerprints (PMF) were recorded in positive ion reflectron mode 
applying 20 kV acceleration voltage. The setting of delayed extraction was set for 
ions with m/z 2000 to get the best results for the relevant peptide m/z range. 
Mass spectra of the relevant for PMF experiments were acquired by accumulating 
200-1000 single unselected laser shots, whereas for PSD MS/MS experiments of 
characteristic tryptic peptides 1000 – 2500 laser shots were averaged. 
 
6.3. Calibration 
 
Mass calibration was performed with a mixture of four standard peptides in the m/z 
range between 750 and 3500 Da. 
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Protein MW monoisotopic [Da] 
Bradykinin 757,3997 
Angiotensin II 1046,5423 
N-acetyl renin 
substrate 
1800,3941 
ACTH 2465,1989 
 
Table 2. List of peptides used for external calibration from 750 to 3500 Da. 
 
6.4. Database search and bioinformatics 
 
All mass spectra and PSD spectra were evaluated with the software supplied with the 
mass spectrometer called Shimadzu Biotech Launchpad 2.7 to get lists of 
monoisotopic or average m/z values of the detected peptides or fragment ions. For 
optimal data presentation PSD spectra were baseline subtracted and smoothed with 
the Savitsky Golay algorithm (3) (Smoothing filter width: 7 channels), whereas mass 
spectra of peptide PMFs were neither baseline subtracted nor smoothed. Each m/z 
data set was submitted to the search engine, either for PMF search or for MS/MS 
search. In some cases it was possible to search with several sequence tags obtained 
from the same spot. 
Searches were run without a limitation or exclusion of species or genera in the public 
Databases MSDB (2006/08/30), NCBInr (2007/06/23), SWISS-PROT (version 53.0) 
and the following search engines Mascot (4), Profound (5) and Aldente (6).  
The following values where used in all searches: 
 
Peptide mass fingerprint (PMF):  
 
• Databases: NCBInr, SWISS PROT, MSDB  
• Search engine: Mascot, Profound, Aldente 
• Enzyme: trypsin (max. 1 missed cleavage) 
• Fixed modification: carbamidomethyl (C) 
• Variable modification: oxidation (M) 
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• Monoisotopic [M+H] + ions 
• Peptide tolerance ± 0,2 Da 
 
MS/MS search: 
 
• Databases: NCBInr, SWISS PROT, MSDB  
• Search engine: Mascot 
• Enzyme: trypsin (max. 1 missed cleavage) 
• Fixed modification: carbamidomethyl (C) 
• Variable modification: oxidation (M) 
• Average masses and tolerance ± 0,8 Da 
 
Only proteins which gave a significant hit in terms of the probability based MOWSE 
Score (significance threshold p˂0,5) as result of PMF and MS/MS search were 
considered as identified. 
In some cases it was necessary to evaluate the MS/MS spectra manually. Therefore 
the differences of the m/z values of all peaks were compared with the known masses 
of all 20 common amino acids. This de novo procedure allowed the identification of 
possible sequence tags from the MS/MS spectra. This sequence tags were blasted 
(NCBI Blast; http://www.ncbi.nlm.nih.gov/blast/Blast.cgi (7)) to get information about 
homologies of these sequence tags.  
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III. Results  
 
 
This study was focused on the proteome of Acanthamoeba castellanii. This organism 
causes a lot of serious infections in humans and because of its ability to form 
resistant cysts the main goal of this work was to identify proteins which are involved 
in cyst formation. First an infectious strain of A. castellanii was isolated from a 
patient, cultured in different cell culture media and studied over the whole period of 
en- and excystment in cell cultures. It was supposed that some characteristic 
changes in the protein pattern in the different stages of cyst formation and 
degradation can be observed. The proteins that changes during the continuous 
cystation process where analysed by the means of a proteomic approach based on 
MALDI-MS and MALDI-MS/MS.  
In addition a nano liquid high performance chromatography MALDI spotting system 
(nLC) was established to perform a separation of the tryptic peptide mix directly after 
in gel digestion of a single spot before analysing with MALDI-MS.  
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Figure 15. Schema of proteomic workflow
 
1. 2D SDS PAGE Gels (Figures 16
 
The proteins in Figure 16 show the ensemble proteome of 
trophozoite stage. In Figure 17 and further in Figure 18
amoebae changes because of the beginning 
proteins disappear from the gel whereas oth
 
-19) 
A. castellanii
-19 the protein pattern of the 
and ongoing encystment. Some 
er proteins become more visible
 
 in its 
. The 
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proteins which were regulated during encystment were of special interest and picked 
for further analysis. 
 
 
 
 
 
 
 
Figure 16. 2D gel of A. castellanii in its trophozoite state (gel was stained with 
Coomassie blue, + proteins detected by Bio-Rad GS-800 scanner) 
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Figure 17. 2D Gel of an A. castellanii cell culture extract in the early stage of its cyst 
stage (gel was stained with Coomassie blue, + proteins detected by Bio-Rad GS-800 
scanner) 
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Figure 18. 2D gel of A. castellanii after 4 hours of incubation in its cyst stage (gel 
was stained with Coomassie blue, + proteins detected by Bio-Rad GS-800 scanner) 
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Figure 19. 2D gel of an A. castellanii culture after 16 hours of incubation in its cyst 
stage (gel was stained with Coomassie blue, + proteins detected by Bio-Rad GS-800 
scanner) 
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2. Identification of protein spots from 2D gels  
 
Spot Alle 1 
 
Figure 20. Peptide mass fingerprint of Alle 1 obtained by MALDI RTOF mass 
spectrometry  
 
Data from 2D gel electrophoresis identify spot Alle 1 as a protein of approximately 50 
kDa with a pI of 6.6 (Figure 15-18). The mass list (see Appendix chapter 6) of the 
PMF (Figure 20) was submitted to Mascot resulting in a significant hit (Score: 81, 
Threshold: 80) for ramosa 3 of Setaria veridis with a calculated molecular mass of 
37,728 kDa and a calculated pI value of 6.29. Thirty-two peptides were used for 
database search where 9 values matched to the proposed protein, giving sequence 
coverage of 32% (figure 21). This significant protein hit was only found in the NCBInr 
database, in all the other databases (Swiss Prot, MSDB) no significant protein hit 
could be obtained.  
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     1 MTKHAGYATD EAVTAVAAPA PAGLHFSPFP PPKVAARDCK KVAALHVDRA  
    51 APGGGGGGSW FESMKASSPR RAADAEHGDWEKHPSALTWEPALAAAKG  
   101 KQIVMFLDYD GTLSPIVEDP DRAVMSEEMR DAVRRVAEQF PTAIVSGRCR  
   151 DKVFNFVKLT ELYYAGSHGM DIEGPAKQSN KHVQANAEEAVHYQAGSEFL  
   201 PIIEEVYRTL TAKMESIAGA KVEHNKYCLS VHFRCVQEEE WKAVEEEVRS  
   251 VLKEYPDLKL THGRKVLEIR PSIKWDKGKA LEFLLKSLGY AGRSDVFPIY  
   301 IGDDRTDEDA FKVLRGMGQG IGILVSKFPK ETAASYXLRD 
Figure 21. Sequence coverage (Matched peptides shown in Bold Red) 
 
Two PSD spectra were generated to confirm the PMF result. Peptide 1 (m/z 1409.71) 
and Peptide 2 (m/z 1543.69) gave no significant hit in none of the databases. It was 
not possible to manually obtain sequence tags from the mass spectra. This means 
that it was not possible to confirm the PMF result with a PSD spectrum. Therefore 
this spot has to be considered as “not identified”, but the PMF gives a hint of a 
potential protein.  
 
Spot Alle 4:  
 
Figure 22. Peptide mass fingerprint of Alle 4 obtained by MALDI RTOF mass 
spectrometry  
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Data from 2D gel electrophoresis identify spot Alle 4 as a protein of approximately 19 
kDa with a pI of 6.0 (Figure 18-19). The PMF is shown in Figure 22. The resulting 
peptide m/z list (see Appendix chapter 6) was submitted to the Mascot search engine 
and a significant hit (Score: 81, Threshold: 67) was found. The protein found in 
SWISS-PROT and NCBI is “Sporulation Specific Chitinase 2 precursor” in yeast with 
sequence coverage of 18% (Figure 23). To achieve this result 17 m/z value were 
submitted whereas 7 matched leading to this protein with a calculated molecular 
mass from 59,366 kDa and a calculated pI of 8.28.  
 
     1 MVGHSAQHRS KSSLVSHLLI LLIFITIIIE MCLYNKIFKN QRSDDIRDNF  
    51 NNGGHRVPSN VQNHGTHIRD EAFISGVYYS NWSPYKPRFH FPHDINLKQV  
   101 SHIYYAFFKI NSRTGGIENT DSWSDLEMNL YKSLAIKNSE LIKESSNNSV  
   151 QNILPLGCIG ELFYLKNTCS DKKFKVIMSI GGWSDSENFK IIIKDDKLLQ  
   201 NFVDSSVETM FRLGFDGIDL DWEFPGNNES EPRGYLKLVR MLRLKLNSLE  
   251 SQIFGKRTED HFQLSIAAPA FKDKLFYLPI TEIDQYVDYW NMMTYDYYGS  
   301 WSETTGYHSN LFSETELNGN FAMHYMIDRF GVNSRKLVLG MAAYGRSFHI  
   351 KDNKFEPFNQ NTVLINKIFK GVGKPTKEID KADGKEGIWP YKNLPKIGTI  
   401 EQYDPKYVSA YCFDEKNSIF ISYDNTKSVK TKAEYVTHNN LGGGFWWESC  
   451 GEAYANESRS LINAFNEGLH FNVSSKPSIF QDVRVKKYYL NKYGDGGFLS  
   501 PYLKHLDSRK Q 
Figure 23. Sequence coverage (Matched peptides shown in Bold Red) 
 
The search with the PSD fragment ion list of the chosen peptide (m/z 1951.76) gave 
no significant protein hit in all databases and therefore did not confirm the protein hit 
found with PMF. Due to the fact that the chosen PSD spectrum contains not much 
fragment peaks; it was not possible to evaluate the PSD spectra manually. Therefore 
this spot has to be considered as “not identified”, but the PMF gives a hint of a 
potential protein.  
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Spot Alle 6: Elongations factor 2 (Dictyostelium discoideum)  
 
Figure 24. Peptide mass fingerprint of Alle 6 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Alle 6 as a protein of approximately 
100 kDa with a pI of 6.5 (Figure 16-19). The PMF is shown in Figure 24.The resulting 
m/z list (see Appendix chapter 6) was submitted to Mascot search and a significant 
hit (Score 77, Threshold: 67) was obtained. The protein found was”Elongations factor 
2” of Dictyostelium discoideum, a fungus related to Acanthamoeba castellanii (see 
chapter 1) with a molecular mass of 92,498 kDa and a calculated pI of 6.22. This hit 
was the result of a search with 24 m/z values whereas 11 values matched and gave 
sequence coverage of 12% (Figure 25).  
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     1 MVNFTIDQIR AIMDRRENIR NMSVIAHVDH GKTTLSDSLI QRAGIIADKV  
    51 SGDMRYMSCR ADEQERGITI KSSSVSLHFE MPKEDKLPAG CTSHEFLINL  
   101 IDSPGHVDFS SEVTAALRVT DGALVVIDCV EGVCVQTETV LRQAVAERIK  
   151 PVLFVNKVDR FLLELQLNTE EAYLSFRRAI ESVNVIVGNT EDKEFGDVTV  
   201 SPEKGTVAFG SGLHGWGFTL GRFAKLYAAK FGDPEDKLMG RLWGDSYFDA  
   251 TAKKWTSNPQ SADGKALPRA FCQFVLEPIY QLTRAIVDED AVKLEKMMKT  
   301 LQITLAPEDA EIKGKQLVKA VMRKFLPAAD AILSMIVTHL PSPLVAQKYR  
   351 CANLYEGPMD DECAVAIQKC DPNGPLMMYV SKMVPTSDKG RFYAFGRVFS  
   401 GIIVPVKRSE LWVSTYVPGK KDDLFLKSIQ RTVLMMGRKT EQIEDCPCGN  
   451 IVGLVGVDQF LVKSGTITTS EVAHNIRVMK FSVSPVVRVA VEPKNPSDLP  
   501 KLVEGLKRLA KSDPCVLCYS EESGEHIVAG AGELHLEICL KDLAEDHAGI  
   551 EIKTTDPVVS FRESVKASPI SMELQDLIEA GSDISSKDDP KARANYLADN  
   601 HEWDKNDAMN IWSFGPEGNG ANLLVNVTKG VQYLNEIKDS FVGAFQWATK  
   651 EGVVCDENMR GIRFNLYDVT LHTDAIHRGG GQIIPTARRV LYAAELTASP  
   701 TLLEPIYLVE ITAPENAIGG IYSVLNRRRG IVIGEERRIG SPLFSVKAHL  
   751 PVLESLRFTA DLRSHTAGQA FPQCVFDHWA SIGVVNKDKK ATEVALATRK  
   801 RKGLAPEIPA LDKFHRKTIN NLSHTLSFQI  
 
Figure 25. Sequence coverage (Matched peptides shown in Bold Red) 
 
To confirm the PMF result a PSD MS/MS experiment was performed on one peptide 
(m/z 760.46) and the resulting fragment ion list was submitted to Mascot search.  
 
 
Figure 26. PSD spectrum of precursor ion m/z 760.7 of the PMF Alle 6  
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The Mascot search of this peptide led to a significant peptide hit based on homology 
with a Mascot ion score of 25 (threshold: ≥24 indicates homology; threshold ≥ 41 
indicates intensity). The 31 most intensive peaks were used leading to 21 fragment 
ions and 13 matched fragment ions and in the end to the following sequence: 
FYAFGR (Figure 26). 
The spot Alle 6 was identified as “Elongations factor 2” but because of the missing 
database entries of this protein in Acanthamoeba castellanii it was only possible to 
find the protein in Dictyostelium discoideum. The identified protein sequence (Figure 
26) belongs to a high conserved region of the second domain of elongation factor 
(EF) EF-2 which can be found in eukaryotes and archea. 
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Spot Alle 7  
 
 
Figure 27. Peptide mass fingerprint of Alle 7 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Alle 7 as a protein of approximately 35 
kDa with a pI of 7.0 (Figure 16-19). Its PMF is shown in figure 27. The list of 
monoisotopic peptide masses (see Appendix chapter 6) was submitted to Mascot 
search, but no significant protein hit was obtained. Therefore MS/MS experiments 
were carried out on 3 peptides (peptide 1: m/z 1410.6, peptide 2: m/z 1591.8 and 
peptide 3: m/z 1713.3) and the resulting fragment ion lists were submitted to Mascot 
search. No peptide sequence or protein hit was obtained by this method, so manual 
interpretation was carried out. 
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Peptide 1: 
 
Figure 28. PSD spectrum of peptide 1 of precursor ion m/z 1410.6 of the PMF Alle 7 
 
Manual interpretation of the spectra allowed the following conclusions: 
 
• y-ion series sequence: (495,07) –TT{E/Q}DDVZTR-(1409.80)  
 
The sequence tag gave no result in any of the databases by any search algorithm 
applied. Therefore a homology search was performed with the sequence to see if this 
sequence allows a result in sequences of closely related organism. The homology 
search was successful and a protein sequence of Entamoeba histolytica was found. 
But this protein is an unknown protein and so no more information can be obtained 
by this data.  
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Peptide 2: 
 
 
Figure 29. PSD spectrum of peptide 2 of precursor ion m/z 1591.8 of the PMF Alle 7 
 
The spectrum of peptide 2 was evaluated manually and lead to the resulting 
sequence: 
 
• b-ion series sequence: (808.27)-DTYDV-(1402.45)  
 
This short sequence tag gave no result in the Mascot search so that we had to do a 
homology search again. This sequence gave a hit (peptide score:21) for the putative 
protein serine/threonine kinase of Dictyostelium Discoideum. The two sequences 
differ in only one amino acid as shown here: 
 
DTYDV.....peptide 2 spot Alle 7 
DTYDK.....Dictyostelium Discoideum 
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This sequence tag is very short and the protein found by homology search gave no 
usefull result.  
 
Peptide 3: 
 
 
Figure 30. PSD spectra of peptide 3 of precursor ion m/z 1713.3 of the PMF Alle 7 
 
The manually evaluation of the spectra of peptide 3 results in a 10 amino acids long 
sequence: (444.36)-EYV{Q/K}ATSVER-(1610.10). It was not possible to evaluate 
from the spectrum whether it is a b- or a y-ion series sequence tag. 
The sequence tag gave no result in any of the databases. Therefore a homology 
search was performed with the sequence to see if this sequence is present in closely 
related organism. The evaluated sequence did not lead to any homology result. 
All manually acquired sequence tags were not only submitted separately but also as 
a combined sequence tag to Mascot using all databases. None of the results 
included more than one of the sequence tags. It is therefore not possible to identify 
this protein with the currently available databases although the mass spectrum of the 
PMF and all PSD spectra were of high quality. Therefore this spot has to be 
considered as “not identified”. 
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Spot Alle 9  
 
 
Figure 31. Peptide mass fingerprint of Spot Alle 9 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Alle 9 as a protein of approximately 75 
kDa with a pI of 6.7 (Figure 15-18). The m/z list (see Appendix chapter 6) of the 
peptide mass fingerprint (Figure 31) was submitted to Mascot search, and a 
significant protein result was obtained. The significant result (Score: 69, Threshold: 
67) was the protein Anthranilate phosphoribosyltransferase in Sulfolobus 
acidocaldarius, a protein with a calculated mass of 37,471kDa and a calculated pI of 
8,73. From 50 m/z values submitted, 9 values matched but and 39% sequence 
coverage was gained. In comparison of the found and the proposed (calculated) m/z 
values, it was astonishing that a lot of the most intense peaks of the spectra did not 
match to the protein found by Mascot search. Therefore MS/MS experiments were 
carried out leading to fragment mass lists (see Appendix chapter 6) for 3 peptides 
(m/z 1003.6, m/z 2038.1 and m/z 2681.4). None of the peaks used for the MS/MS 
experiment was found in the mass list of the significant protein hit found by PMF. All 
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mass lists were submitted separately to Mascot search and none of the searches 
allowed the identification of a peptide or protein.  
 
Peptide 3: 
 
Figure 32. PSD of peptide 3 of precursor ion m/z 2681.4 of the PMF Alle 9 
 
The spectra of peptide 3 allowed a manual interpretation leading to the following 
sequence: 
 
• (1660.33)-VHWGA-(2209.91).  
 
It was not possible to evaluate whether it is a b- or y-ion series sequence. 
The sequence was submitted to Mascot and a homology search was performed but 
did not lead to an identification of spot Alle 9.  
Due to the fact that the spectrum of the PMF of spot Alle 9 and the protein 
Anthranilate phosphoribosyltransferase show a lot of differences in the mass spectra 
and the MS/MS data did not give significant results, the conclusion is that this spot 
cannot be considered as “identified”. 
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Spot Cyst 1  
 
Figure 33. Peptide mass fingerprint of Spot Cyst 1 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Cyst 1 as a protein of approximately 
55kDa with a pI of 6.3 (Figure 16). The m/z list (see Appendix chapter 6) of the 
peptide mass fingerprint (Figure 33) were submitted to Mascot search, and a 
significant protein result for the protein vacuolar ATP synthase subunit B 1 from Hordeum 
vulgare (Score: 74, Threshold 67) was obtained. This protein has a molecular mass of 54,107 kDa 
and a calculated pI of 5.12. For this hit 31 m/z values were submitted to Mascot whereas 7 m/z values 
matched giving sequence coverage of 15% (Figure 33).  
 
     1 MGLVKEGADM EEGTLEIGME YRTVSGVAGP LVILDKVKGP KYQEIVNIRL  
    51 GDGTTRRGQV LEVDGEKAVV QVFEGTSGID NKYTTVQFTG EVLKTPVSLD  
   101 MLGRIFNGSG KPIDNGPPIL PEAYLDISGS SINPSERTYP EEMIQTGIST  
   151 IDVMNSIARG QKIPLFSAAG LPHNEIAAQI CRQAGLVKRL EKGKHAEGGG  
   201 EDDNFAIVFA AMGVNMETAQ FFKRDFEENG SMERVTLFLN LANDPTIERI  
   251 ITPRIALTTA EYLAYECGKH VLVILTDMSS YADALREVSA AREEVPGRRG  
   301 YPGYMYTDLA TIYERAGRIE GRTGSITQIP ILTMPNDDIT HPTPDLTGYI  
   351 TEGQIYIDRQ LHNRQIYPPI NVLPSLSRLM KSAIGEGMTR RDHSDVSNQL  
   401 YANYAIGKDV QAMKAVVGEE ALSSEDLLYL EFLDKFERKF VAQGAYDTRN  
   451 IFQSLDLAWT LLRIFPRELL HRIPAKTLDA FYSRDAAH 
 
Figure 34. Sequence coverage (Matched peptides shown in Bold Red) 
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It was not possible to perform PSD MS/MS experiments because the molecular ions of interest were 
lying too close together. Without any MS/MS fragment data to verify the PMF result the spot is cannot 
be considered to be identified.  
 
Spot Cyst 3  
 
 
Figure 35. Peptide mass fingerprint of Cyst 3 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Cyst 3 as a protein of approximately 
14 kDa with a pI of 5.2 (Figure 16). The m/z list (see Appendix chapter 6) of the PMF 
(Figure 35) was submitted to Mascot search, and no significant result could be 
obtained. 
 
Therefore PSD MS/MS experiments were performed giving PSD spectra of 3 
peptides (peptide 1: m/z 949.8 [Figure 36], peptide 2: m/z 1164.9[Figure 37] and 
peptide 3: m/z 2153.5 [Figure 38]). 
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Peptid 1: 
 
 
Figure 36. PSD spectrum of peptide 1 of precursor m/z 949.8 of the PMF Cyst 3  
 
The fragment ion list (see Appendix chapter 6) was submitted to Mascot but no result 
was obtained. Therefore manual evaluation was carried out leading to the following 
amino acid sequence: 
 
• (0.0)-MDAASDA-(837.06) 
 
It was not possible to evaluate from the spectrum whether it is a b- or a y-ion series 
sequence. For this sequence tag no homologies were found 
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Peptide 2: 
 
 
Figure 37. PSD spectrum of peptide 2 of precursor m/z 1164.9 of the PMF Cyst 3  
 
The fragment mass list (see Appendix chapter 6) was submitted to Mascot search 
engine gave no result therefore manual evaluation was performed leading to the 
following sequence: 
 
• (301.16)-TWANFV-(1013.14)  
 
It was not possible to evaluate from the spectrum whether it is a b- or a y-ion series 
sequence. For this sequence tag no homologies were found.  
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Peptide 3: 
 
 
Figure 38. PSD spectrum of peptide 3 of precursor m/z 2153.5 of the PMF Cyst 3  
 
The fragment mass list of peptide 3 (see Appendix chapter 6) gave no result in none 
of the databases. Due to the fact that there were enough peaks for manually 
interpretation it was possible to get the following sequence:  
 
• (1000.29)-ESF{Q/K}{I/L}D{Q/K}E-(2008.99) 
 
It was not possible to evaluate from the spectrum whether it is a b- or a y-ion series 
sequence 
Homology search was performed resulting in a hypothetical protein of Entamoeba 
hystolytica with the following sequence:  
 
• KMFQEDQE. 
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Due to the fact that the protein we found by homology search is not identified yet, we 
are not able to get an additional hint for the identification of this spot. 
Combination of sequence tags: 
 
Three PSD spectra were generated to confirm the PMF result. All peptides gave no 
significant hit in none of the databases. It was possible to get sequence tags out of 
three spectra by evaluating the spectra manually. The resulting sequence tags were 
submitted separately but also together in one Mascot sequence query to all 
databases. None of the results included more than one of the sequence tags. The 
logical conclusion is the impossibility of protein identification with this data. 
Due to the fact that it was not possible to confirm the PMF result with a PSD spectra 
this spot has to be considered as “not identified”. 
 
Spot Cyst 4  
 
 
Figure 39. Peptide mass fingerprint of Spot Cyst 4 obtained by MALDI RTOF mass 
spectrometry 
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Data from 2D gel electrophoresis 
70 kDa and a pI with 5.3 (Figure 16)
PMF (Figure 39) a Mascot search was done leading to no significant protein hit. A lot 
of unspecific protein hits were 
identification of spot Cyst 4. 
 
Peptide 1:  
 
Figure 40. PSD spectrum of peptide 1 of precursor m/z 1345.8 of the PMF Cyst 5
 
MS/MS experiments were performed and the fragment mass lists were submitted to 
the databases NCBI and Mascot but do not lead to any results. It was possible to 
evaluate one spectrum manually, leading to the following sequence: 
 
• (175.15)-NTSYYNEDA-(1232.49
 
It was not possible to evaluate from the spectrum whether it is a b
sequence. 
identify spot Cyst 4 as a protein of approximately 
. With the m/z list (see Appendix chapter 6) of the 
reached but none of them could give us a hint for the 
 
) 
- or a y
 
 
-ion series 
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With this sequence we performed a homology search using protein prospector 
leading to a sequence of Entamoeba histolytica. These two sequences differ in 4 
amino acids. 
RNTSYYNEDA...Cyst 4 
RNSCYYGEDK...Entamoeba histolytica 
 
Due to the fact that the found protein of Entamoeba histolytica is a hypothetical 
protein, it is not possible to get a hint for identification of this spot. 
The performed experiments did not lead to identification of the spot Cyst 4 because 
neither the PMF nor the MS/MS fragment data did give us certain results.  
 
Spot Cyst 5  
 
 
Figure 41. Peptide mass fingerprint of spot Cyst 5 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Cyst 5 as a protein of approximately 
40 kDa with a pI of 6.6 (Figure 17). The m/z list (see Appendix chapter 6) from PMF 
(Figure 41) was submitted to the databases but no significant result was obtained. 
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Therefore MS/MS experiments were performed.
one peptide spectrum (m/z 1836.8) that was submitted to Mascot search.
 
Peptide 1:  
 
Figure 42. PSD Spectrum of peptide 1
 
It was possible to evaluate the spectrum manually leading to the following sequence: 
• (641.3)-ND{I/L}V{I/L}AQ
It was not possible to evaluate from the spectrum whether it is a b
sequence. 
This sequence was found in the databases with high homology to the protein 
sequence of Phosphofructokinase from Entamoeba histolytica. 
 
ND{I/L}V{I/L}AQ.....Cyst 5
ND  L   L  I   AQ.....Phosphofructokinase Entamoeba histolytica
 
 The MS/MS experiment delivered 
 of precursor m/z 1836.8 of the PMF Cyst 5
-(1394.9).  
- or a y
 
 
 
 
 
 
-ion series 
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The protein Phosphofructokinase is an enzyme involved in the main metabolism of all 
living organisms therefore it can be found in nearly every organism in high amounts. 
The PMF data did not proof the result of the homology search. The reason is that 
there were either too few peak values in the PMF or the peak values in the PMF were 
not specific enough get a significant hit in the databases. In the PMF spectrum 
(Figure 41) there is a gap between m/z 1200-2163 with very few peaks with low 
intensities but just in this area the most specific peaks for this enzyme were 
assumed. Further PMF data of this spot has to be collected to proof the identity.  
 
Spot Cyst 6  
 
 
Figure 43. Peptide mass fingerprint of spot Cyst 6 obtained by MALDI RTOF mass 
spectrometry 
 
 
Data from 2D gel electrophoresis identify spot Cyst 6 as a protein of approximately 
25 kDa and a pI of 7.2 (Figure 17). The m/z list (see Appendix chapter 6) of the 
peptide mass fingerprint (Figure 43) was submitted to Mascot resulting in a significant 
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hit for Myb family DNA binding protein from Entamoeba histolytica (Score:80, 
Threshold:80). This protein with a mass of 27599 Da and a calculated pI of 7.39 fits 
very well to the information resulting from its position on the 2D gel. From 14 m/z 
values submitted to Mascot, 7 values matched leading to sequence coverage of 21% 
(Figure 44).  
 
     1 MSTFGNAAGV IWRNTEDEVL KAGVMKYGKN EWARISSLIA GKSPQQCKAR  
    51 WYSWLDPSIK KTEWTSTEEE KLLHLIKIFP SQWQTISKSV GRTPAQCIEK  
   101 YNQLKDEATG DDCSGLREKE MNEIIPETRP ALKDRVDLDD DEIEMLNEVR  
   151 ARLANTKGKK AKRKERQKLQ QDTAYATELQ KRRELRAAGI QVSYSHKIKG  
   201 PDYNSEIPFF REVPQGKFNP QKDRKPPKKP SFIGKEMN 
 
Figure 44. Sequence coverage (Matched peptides shown in Bold Red) 
 
To get more sequence information MS/MS experiments were performed but none of 
the chosen peptides gave evaluable PSD spectra. The peaks chosen for PSD did not 
fragment so that no PSD spectrum could be made. Due to the fact that the protein 
found with PMF data did not give us a high significant hit and that it was not possible 
to verify the PMF result with PSD MS/MS results this spot is considered as “not 
identified”. 
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Spot Cyst 8  
 
 
Figure 45. Peptide mass fingerprint of Cyst 8 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify spot Cyst 8 as a protein of approximately 
45 kDa and a pI of 7 (Figure 17) was analysed and the m/z list of the peptide mass 
fingerprint (Figure 45) was submitted to the databases resulting in no significant hit. 
Subsequent PSD MS/MS experiments were done and fragment m/z lists of one 
peptide (average m/z 1990.1) was used to make a Mascot query.  
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Peptide 1: 
 
 
Figure 46. PSD spectrum of peptide 1 of precursor m/z 1990.1 of the PMF Cyst 
 
Manual interpretation leads to the following sequence tag:  
 
• (519.96)-F{Q/K}WSWYTEVD-(1862.53) 
 
The sequence and the fragment mass list were submitted to Mascot search but no 
significant hit could be obtained. With the sequence a homology search was 
performed but no homologies were found.  
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Spot Cyst 9  
 
 
Figure 47. Peptide mass fingerprint of Cyst 9 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify Spot Cyst 9 as a protein of approximately 
100 kDa and a pI of 7.2 (Figure 17).Even though that the peptide mass fingerprint 
consisted of enough m/z values it was not possible to get a significant protein hit in 
none of the used databases. The mass lists (see Appendix chapter 6) were submitted 
to SWISS PROT, NCBInr and MSDB and produced a lot of low significant hits with 
Mascot scores of 80 (Threshold 80) but none of them was fitting in weight and pI with 
the data from the 2D gel. This situation made it essential to do MS/MS experiments 
to get more certain results to work with. The peptide mass fingerprint made it not 
easy to get PSD spectra because the peaks were very close together. It was possible 
to get an evaluable spectrum from one peptide (average m/z 1087.9, Figure 48). The 
fragment ion list was submitted to Mascot search but no significant result was 
obtained. 
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Peptide 1: 
 
 
Figure 48. PSD spectrum of peptide 1 of precursor m/z 1087.9 of the PMF Cyst 9  
 
It was possible to evaluate one spectra manually leading to the following sequence:  
 
• (0.0)-(R)GGYGNHATN-(973.78) 
 
A homolog sequence was found after homology search in Dictyostelium Discoideum.  
 
RGGYGNHATN....Cyst 9 
DGGYGSKASR....Dictyostelium Discoideum 
 
This sequence was described as hypothetical protein so that we are not able to get 
another hint for the identification of Cyst 9.  
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Spot Enc 2- Actin 1  
 
 
Figure 49. Peptide mass fingerprint of Enc 2 obtained by MALDI RTOF mass 
spectrometry 
 
Data from 2D gel electrophoresis identify Spot Enc 2 as a protein of approximately 32 
kDa and a pI of 5.7 (Figure 17-19). The m/z list (see Appendix chapter 6) of the PMF 
(Figure 49) was submitted to Mascot resulting in a high significant hit for actin in 
Acanthamoeba castellanii (Score: 109 Threshold: 67) with a calculated molecular 
mass of 41877 Da and a calculated pI of 5.37. To receive these result 19 m/z values 
were submitted whereas 12 masses matched giving sequence coverage of 41% 
(Figure 50).  
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     1 MGDEVQALVI DNGSGMCKAG FAGDDAPRAV FPSIVGRPRH TGVMVGMGQK  
    51 DSYVGDEAQS KRGILTLKYP IEHGIVTNWD DMEKIWHHTF YNELRVAPEE  
   101 HPVLLTEAPL NPKANREKMT QIMFETFNTP AMYVAIQAVL SLYASGRTTG  
   151 IVLDSGDGVT HTVPIYEGYA LPHAILRLDL AGRDLTDYLM KILTERGYSF  
   201 TTTAEREIVR DIKEKLCYVA LDFEQEMHTA ASSSALEKSY ELPDGQVITI  
   251 GNERFRAPEA LFQPSFLGME SAGIHETTYN SIMKCDVDIR KDLYGNVVLS  
   301 GGTTMFPGIA DRMQKELTAL APSTMKIKII APPERKYSVW IGGSILASLS  
   351 TFQQMWISKE EYDESGPSIV HRKCF 
 
Figure 50. Sequence coverage (Matched peptides shown in Bold Red) 
 
To proof the result of the PMF, PSD MS/MS experiments of peptide m/z 1790.4 
(Figure 51) were performed. The fragment ion list (see Appendix chapter 6) which 
was submitted to Mascot and a significant hit for actin (Score 54, Threshold: 41) from 
Dictyostelium Discoideum was received. It was not possible to find fragment ion data 
entries of protein actin from A.castellanii in any of the used databases and because 
of high conserved sequences (Figure 49a) the fragment mass search resulted in a 
significant hit of the near related organism Dictyostelium Discoideum.  
The spot Enc 2 was identified as protein actin. 
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Peptide 1: 
 
Figure 51. PSD of peptide 1 of precursor m/z 1790.5 of the PMF Enc 2 
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2.1. Summary 
This table shows up all 39 spots which were measured during this diploma thesis. All 
mass lists for PMF and all fragment mass lists are shown in the appendix section of 
this work (chapter 6). 
Spots 
(name) PMF MS/MS result 
Enc1 yes no no identification 
Enc 2 yes yes actin  
Enc 3 yes no no identification 
Enc 4 no no no identification 
Enc 5 yes yes no identification 
Enc 6 yes yes no identification 
Enc 7 no no no identification 
Enc 8 yes no no identification 
Enc 9 yes yes no identification 
Enc 10 yes yes no identification 
Enc 11 yes yes no identification 
Enc 12 no no no identification 
Enc 13 no no no identification 
Enc 14 no no no identification 
Enc15 no no no identification 
Tropho1 yes no no identification 
Tropho2 yes yes no identification  
Tropho3 no no no identification 
Tropho4 no no no identification 
Tropho5 no no no identification 
Cyst1 yes no suspision: Vacuolar ATP synthase subunit B1 
Cyst2 yes yes no identification 
Cyst3 yes yes no identification 
Cyst4 yes yes no identification 
Cyst5 yes yes suspision:Phosphofructokinase 
Cyst6 yes yes suspision: Myb family DNA binding protein 
Cyst7 no no no identification 
Cyst8 yes yes no identification 
Cyst9 yes yes no identification 
Alle1 yes yes suspision:Ramosa 3 
Alle2 no no no identification 
Alle3 yes yes no identification 
Alle4 yes yes 
suspision: Sporulation specific chitinase 2 
precursor 
Alle5 no no no identification 
Alle6 yes yes Elongation factor 2 
Alle7 yes yes suspision: protein serine/threonin kinase 
Alle8 no no no identification 
Alle9 yes yes no identification 
Alle10 yes yes no identification 
 
Table 8. Overview over the results of all analysed spots (red: identification; blue: 
suspicions; green: not identified) 
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3. Identification of a protein spot using nano HPLC MALDI 
Spotter (nLC Spotter) 
 
The aim of the second part of the work was to develop a nLC procedure for protein 
identification after in gel digestion. (Settings see chapter materials and methods) 
 
On this account a prominent protein was chosen to demonstrate the identification 
using nLC-Spotter device. The chosen protein is actin from Entamoeba histolytica (e-
actin) with a molecular weight of 42 kDa and a pI of 5.19. The peptide mass 
fingerprint of this protein without proceeding separation is shown in Figure 52.The 
peptide mass fingerprint m/z list (see appendix chapter 6) was submitted to Mascot 
giving a significant hit for actin (score: 91, threshold: 67).To receive this result 12 
mass values were submitted whereas 8 values matched giving sequence coverage of 
27% (Figure 53).  
 
Figure 52. PMF spectrum of spot e-actin (sample preparation: dried droplet) 
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   1 MGDEEVQALV VDNGSGMCKA GFAGDDAPRA VFPSIVGRPR HVSVMAGMGQ  
    51 KDAYVGDEAQ SKRGILTLKY PIEHGIVNNW DDMEKIWHHT FYNELRVAPE  
   101 EHPVLLTEAP MNPKANREKM TQIMFETFNT PAMYVGIQAV LSLYASGRTT  
   151 GIVMDSGDGV SHTVPIYEGF SLPHAILRLD LAGRDLTDYL MKILTERGYA  
   201 FTTTAEREIV RDIKEKLCYV AEDFNEEMQK AASSSELEKS YELPDGQVIT  
   251 VGNERFRCPE ALFQPSFLGM ECNGIHETTY NSIMKCDVDI RKDLYGNIVL  
   301 SGGTSMYPGI NTRLEKEMIQ LAPPTMKIKV IAPPERKYSV WIGGSILASL  
   351 STFQNMWITK EEYDESGPAI VHRKCF 
Figure 53. Matched peptides shown in Bold Red 
 
In comparison the spectra of the nanoLC experiment (Figure 51). 
 
 
Figure 54. Mass spectra of spotted fractions 6-11 of spot E-actin 
 
Figure 54 shows 5 mass spectra representative from the nLC experiment. These 
mass spectra and fractions were chosen as they contain the tryptic peptide peaks 
which are important for the identification of this e-actin. You can see in figure 54 that 
the intensive peaks with the m/z values 1260.71 and 1776.81 are separated in 
different spotted fractions. In more complex samples this separation step can help 
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the identification because of getting rid of contaminations and other troublesome 
peaks which make it impossible to get reproducible PSD spectra. It is also possible to 
see peaks that could be suppressed by other more intense peaks and in a lot of 
cases this small peaks are important for the identification. It can also be observed 
that peak detection gets improved. For the ion at m/z 1260.71, which is less intensive 
in Figure 52, the signal improves significant (Figure 54). Therefore problematic peak 
detection due to ion suppression effect can be avoided.  
 
Peptide 1: 
 
 
Figure 53. PSD spectrum of spot E-actin 
 
The PSD spectrum was generated from tryptic peptide with a protonated molecular 
ion m/z 1776.5 of spotted fraction 9 (orange spectrum in figure 54) because of the 
highest intensity. The resulting fragment mass list (see Appendix chapter 6) was 
submitted to Mascot search obtaining a significant hit (Score 55, Threshold 41) for 
the protein actin of Entamoeba histolytica. 
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Sequences of protein actin:  
 
• SYELPDGQVITIGNER........ Acanthamoeba castellanii (spot Enc 2) 
• SYELPDGQVITVGNER....... Entamoeba histolytica 
 
In comparison of the two sequences the actin sequences of peptide m/z 1776.5 (E. 
histolytica) and peptide m/z 1790.4 (A. castellanii) differ in one amino acid. The well 
known protein actin is a protein which can be found ubiquity in every organism with 
very few changes in its sequence. The identification of this spot with nLC Spotter 
MALDI was successful. It was possible to show that a separation step can improve 
the PMF and PSD spectra. This can be seen in the much higher scores and 
improved PSD spectrum. 
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IV. Discussion 
 
One part of this work was to analyse 39 2D PAGE Spots from Acanthamoeba 
castellanii by PMF and MALDI PSD MS/MS. The main reason for these experiments 
was to get more information’s about the proteins involved in the cyst formation and 
degradation. From a large part of proteins identification was not possible because of 
missing data in all of the used databases. In the database there were only 127 
entries for Acanthamoeba castellanii proteins and a large part were only fragments of 
proteins calculated from genetic approaches. One of the main reasons why there is 
so few information available is that the genome of A. castellanii is not sequenced and 
that the number of people working with this special organism, despite of its medical 
relevance, is low. 
With this small amount of information from the databases it was only possible to get a 
proposal for most of the proteins through homology search of the sequence tags that 
were obtained by evaluating the PSD spectra manually. In some cases it was 
possible to identify a protein because of the conserved sequence of this protein is 
present in related species. 
A second reason for problems with the identification of the protein spots was that 
some spots have been stored for nearly one year before analysis. In some cases it 
was not even possible to get A PMF because it was not possible to eluate the tryptic 
peptides out of the gel matrix. It was not possible to repeat all problematic spots but 
in some very important cases, there was the opportunity to analyse spots from freshly 
prepared gels which turned out to work well. 
Another problem we were confronted with was a microbiological contamination of the 
cell culture of A. castellanii resulting in a lot of spots which do not only contain A. 
castellanii proteins but also proteins from the other organism. In a few cases there is 
also the suspicion that the spot contained not only one protein but several. 
Nevertheless, it was possible to identify unambiguously 2 spots, namely Enc 2 and 
Alle 6. The spot Enc 2 was identified as actin and the spot Alle 6 was identified as 
elongation factor 2 .In both cases the PMF and the PSD MS/MS results matched 
despite it was not possible to get complete identity match by the databases because 
of the missing A. castellanii data entries. 
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V. Conclusion 
 
The organism Acanthamoeba castellanii belongs to the species Amoebae and is 
distributed worldwide. It is well known for serious infection in humans e.g. 
Acanthamoeba Encephalitis (GAE) and Acanthamoeba keratitis. The lifecycle of all 
amoebic species consists of 2 stages: an active dividing trophozoite and a dormant 
cyst stage. The cysts of A. castellanii are of special interest because of its resistance 
to biocides and disinfectants. Nearly nothing is known about the proteins involved in 
the formation and degradation of its cysts. The organism was studied over the whole 
period of encystment in cell culture and in each life stage samples were taken. With 
these samples 2D gel electrophoresis was performed and the spots of interest were 
cut out of the gel. The identification of the proteins of the A. castellanii was performed 
by tryptic in-gel digestion. Afterwards the analyses were performed by MALDI RTOF 
MS and sequence tag determination with MALDI PSD MS/MS and nLC MALDI MS. 
The experiments lead to the identification of 2 spots Enc 2 and Alle 6. Enc 2 was 
identified as protein actin and Alle 6 was identified as protein elongations factor 2. All 
the other data from the experiments, despite there are of good quality, have to be 
evaluated later on when the databases are updated with more sequence data for A. 
castellanii.  
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VI. Appendix 
Peptide mass fingerprints and PSD of all measured spots. 
 m/z values→ intensity 
Alle 1_PMF 753.36 95916984.00 
1008.52 18992488.00 
1089.52 8409352.00 
1291.57 12048965.00 
1328.62 6277300.00 
1409.71 60936872.00 
1419.67 7915648.50 
1504.71 6096929.00 
1543.69 82359184.00 
1559.67 9041157.00 
1616.74 9616793.00 
1640.58 14329890.00 
1688.73 33835704.00 
1704.72 18864322.00 
1765.75 6040759.00 
1791.79 4331428.50 
2004.97 6402269.00 
2018.04 5068712.00 
2051.84 1403783.50 
2083.95 6534823.00 
2100.96 16249541.00 
2178.01 4475284.00 
2203.03 6521727.00 
2219.10 4893694.00 
2326.00 3513983.50 
2339.15 4004867.75 
2358.12 7439837.50 
Alle 1_1409.71PSD 166.7 5101.1 
175.4 11254.4 
176.6 6052.8 
200.2 5153.6 
234.6 5999.2 
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258.3 5527.9 
262.6 5575.6 
288.4 5144.1 
390.6 10002.2 
430.5 8434.9 
447.7 20473.3 
464.5 7827.1 
512.5 8100.1 
519.1 8357.2 
530.6 8396.5 
547.0 11164.3 
601.1 10885.3 
630.6 8538.9 
647.9 11764.6 
749.3 7462.2 
764.7 15011.1 
777.2 7069.4 
793.9 7296.3 
811.3 7447.6 
848.0 8134.8 
865.1 10721.5 
1003.6 7611.7 
1021.4 14412.2 
1038.0 7870.0 
1089.5 7698.8 
1092.6 8093.0 
Alle1_1543.69 PSD 110.6 6226.5 
111.2 5851.8 
157.1 6060.8 
175.5 6176.7 
257.3 11328.1 
285.4 18711.9 
322.0 6759.2 
322.9 6223.8 
414.7 9717.6 
432.8 16495.9 
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457.7 11969.4 
474.7 18947.0 
519.9 9758.7 
533.7 9348.5 
544.4 9674.5 
561.6 11377.4 
661.0 10544.5 
704.3 13232.0 
721.5 17268.4 
825.0 11926.1 
857.7 19970.3 
867.8 14747.7 
885.7 17467.6 
911.2 16040.9 
957.1 10940.3 
985.2 17583.3 
1010.5 15594.6 
1052.2 11206.3 
1066.0 16550.2 
1072.4 14537.5 
1114.3 10468.8 
1204.9 10501.9 
1296.8 13885.4 
1389.2 13980.5 
1408.7 19773.6 
1435.5 15229.7 
1468.4 18765.5 
1495.3 23841.5 
1499.8 96654.7 
1502.1 97410.7 
Alle1_2084.94 PSD 209.4 4664.3 
306.1 4230.7 
353.6 4808.8 
354.4 4483.3 
356.0 4205.2 
375.5 5056.8 
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385.0 4427.8 
385.7 5897.1 
476.7 6216.3 
478.1 5682.8 
551.8 36253.9 
649.2 6348.5 
724.1 87276.3 
793.2 8690.5 
821.3 7722.7 
839.4 7055.0 
893.5 5225.6 
907.6 4879.0 
919.0 19612.0 
936.0 15423.2 
1049.2 5786.4 
1050.8 4858.4 
1106.2 9255.8 
1227.3 5487.8 
1252.4 7615.5 
1269.5 93854.6 
1366.8 6691.1 
1384.3 8535.6 
1411.0 5751.7 
1605.8 5689.6 
1611.8 6136.8 
Alle 3_PMF 807.47 1957263.63 
976.55 1574529.38 
993.52 56699996.00 
1019.55 8803821.00 
1055.40 9351880.00 
1102.60 23506714.00 
1134.56 1906066.63 
1164.58 4573702.00 
1198.75 5777284.50 
1235.69 1393060.25 
1260.67 1513025.25 
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1320.69 4336532.00 
1355.79 3249923.00 
1382.87 36443124.00 
1444.76 2623351.25 
1501.77 26488610.00 
1563.70 3414269.00 
1642.82 1472789.75 
1670.12 2994679.75 
1765.86 5146702.50 
1790.99 17747630.00 
1822.98 6600698.50 
1962.02 9105445.00 
Alle 3_1383.79 PSD 623.83 
640.92 
744.00 
1325.39 
1339.28 
1348.60 
1351.77 
1355.82 
1366.44 
1369.53 
1380.28 
1383.04 
1383.44 
1384.03 
1385.05 
1386.01 
1387.03 
1388.65 
1390.85 
1395.12 
1396.15 
Alle 4_PMF 852.52 7481221.00 
1109.44 2904700.25 
1141.46 921344.00 
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1153.47 2712442.50 
1178.48 5926535.50 
1235.44 5084520.50 
1253.47 9102947.00 
1269.48 2679421.75 
1319.63 9293548.00 
1352.45 2767450.25 
1491.51 2507171.50 
1642.55 10901705.00 
1791.56 12772717.00 
1917.57 9421608.00 
1951.76 37026128.00 
2013.71 3885083.50 
2188.88 7210349.50 
Alle 6_PMF 760.46 117694928.00 
822.43 5701727.00 
856.68 20780950.00 
890.68 5613120.50 
969.72 7596339.50 
1021.68 6536302.00 
1096.65 117694928.00 
1105.76 66001744.00 
1236.70 8031189.00 
1344.96 5444233.00 
1378.91 43488472.00 
1487.93 17934558.00 
1534.99 96749336.00 
1596.93 10739001.00 
1622.93 5906586.50 
1683.00 31207192.00 
1910.17 44331764.00 
1964.19 10021415.00 
2024.27 210541936.00 
2086.16 8810368.00 
2180.33 39290700.00 
2237.37 3548004.75 
98  
 
2242.31 2953927.25 
2249.31 2528357.25 
Alle 6_760.88 PSD 112.6 56455.0 
120.6 96761.3 
121.7 16961.6 
129.4 17744.8 
136.4 54386.5 
155.3 16011.9 
155.6 19936.0 
156.0 19671.0 
157.6 15830.8 
158.4 53421.5 
161.4 38717.6 
172.3 16682.0 
172.7 15061.9 
175.5 192315.0 
191.6 42348.7 
192.7 14485.1 
205.1 13782.6 
205.5 24913.2 
215.5 209462.3 
219.5 52449.1 
232.6 78171.5 
Alle 6_2026.37 196.3 24084.0 
295.0 74864.7 
407.8 26680.9 
409.4 18527.2 
488.3 17350.6 
523.9 19575.8 
734.9 29587.6 
753.9 30988.5 
880.8 19388.4 
882.2 21801.0 
990.2 39233.4 
1009.6 18844.3 
1011.4 22276.1 
99  
 
1021.1 37561.1 
1038.8 47434.1 
1040.4 19504.0 
1129.5 25564.0 
1146.6 26864.8 
1221.2 22991.0 
1249.5 23599.7 
1265.6 35626.9 
1275.0 78396.0 
1292.4 20689.3 
1293.1 20275.5 
1403.7 47162.2 
1475.5 25032.3 
1532.5 28071.9 
1534.6 21622.7 
1620.3 28330.4 
1638.2 24670.1 
1684.3 34488.8 
Alle 7_PMF 807.45 5083158.50 
824.50 4567702.00 
914.51 6028881.00 
983.56 2985614.25 
1072.67 2641364.00 
1124.58 1522152.63 
1284.70 5587531.00 
1344.77 27749952.00 
1409.80 99057544.00 
1422.77 12083996.00 
1536.93 9459671.00 
1590.88 77813528.00 
1613.99 123272720.00 
1712.04 79674512.00 
1759.07 14013740.00 
1868.13 37316628.00 
1889.05 8347822.00 
1903.20 4049071.00 
100  
 
1919.14 3437363.50 
2233.31 3639579.50 
2254.40 6252691.50 
 
Alle 7_1591.20 PSD 581.0 7384.3 
582.1 7393.8 
685.5 13940.0 
785.2 12858.3 
790.4 6921.5 
808.2 117694.2 
907.4 18035.6 
1022.4 10569.6 
1185.8 6862.6 
1286.9 7414.2 
1485.8 7940.4 
1488.6 7312.4 
1489.9 7552.1 
1535.4 7197.3 
Alle 7_1616.37 PSD 381.5 3741.6 
683.2 4153.1 
782.3 4368.0 
799.8 19085.6 
805.3 18439.9 
904.7 3853.8 
1143.9 3897.6 
1183.8 4442.4 
1200.6 3460.5 
1226.5 3615.6 
1284.3 4406.5 
1328.0 4598.8 
1371.2 3798.8 
1402.7 3781.9 
1407.3 3993.2 
1441.6 5660.9 
1469.1 5093.1 
1486.7 27181.6 
101  
 
1500.8 3559.8 
1502.3 3608.4 
1504.8 4227.1 
1513.2 3767.2 
1526.0 3793.4 
1537.0 3622.9 
1538.9 3702.4 
1540.6 3727.7 
1543.8 4340.1 
1548.8 3891.3 
1555.4 4675.7 
1570.5 10953.7 
Alle 7_1714.16 PSD 444.8 11164.5 
574.3 5756.8 
574.7 5116.4 
737.1 12671.3 
739.6 5395.5 
749.5 6327.7 
837.6 9546.8 
877.5 12121.0 
948.3 5686.0 
965.2 7968.5 
976.5 11391.0 
1035.5 7107.5 
1138.0 8295.2 
1139.2 5696.8 
1225.2 10451.4 
1253.0 5224.6 
1260.2 5455.2 
1267.2 6722.5 
1268.8 6524.1 
1323.0 7655.3 
1324.8 6088.3 
1335.2 4971.8 
1401.7 5820.6 
1453.8 6066.1 
102  
 
1566.0 5010.4 
1610.3 10220.5 
1613.7 6276.3 
1668.2 5200.1 
1672.3 6151.7 
1673.4 5277.1 
1673.8 5608.9 
Alle 9_PMF 869.02 4321356.00 
877.52 8179296.00 
1003.63 108987400.00 
1075.74 40233448.00 
1088.70 30008460.00 
1131.73 100176192.00 
1144.66 16367896.00 
1203.79 11723379.00 
1267.77 2969839.25 
1339.75 7495841.50 
1373.86 26933128.00 
1435.81 3421982.75 
1480.87 4299777.00 
1490.89 7862177.00 
1539.97 5819667.00 
1616.91 869571.75 
1636.94 7530523.50 
1645.95 24123864.00 
1697.10 6754672.00 
1707.91 7473836.50 
1728.08 12417830.00 
1777.07 15303065.00 
1826.16 38798648.00 
1916.06 13518428.00 
1920.12 11883484.00 
1928.07 4510640.00 
1954.20 16291396.00 
Alle 9_1004.22 PSD 175.2 5624.9 
274.6 8136.2 
103  
 
276.4 12035.0 
356.6 11457.2 
375.5 5698.3 
403.5 6537.4 
455.7 9853.7 
587.8 7555.9 
594.7 5382.1 
612.6 39173.3 
629.8 19149.9 
631.0 8573.9 
632.1 6511.8 
666.7 6080.5 
686.8 5616.2 
693.4 6043.6 
699.8 6920.9 
703.2 5946.3 
710.9 6725.7 
711.7 8973.9 
729.0 6421.3 
731.7 5894.0 
736.8 5647.9 
740.1 5815.7 
748.5 7985.0 
754.3 6712.3 
760.2 5741.3 
763.0 5926.6 
767.6 5723.6 
794.4 7471.6 
818.0 7248.9 
Alle 9_2039.25 PSD 710.7 13962.2 
854.7 25860.8 
975.5 14336.2 
975.9 14289.5 
1066.3 15331.1 
1185.7 45297.5 
1253.0 14344.2 
104  
 
1272.0 17214.2 
1273.5 17397.7 
1329.3 43139.1 
1380.8 20858.9 
1450.9 13973.1 
1467.5 53286.1 
1479.0 14105.4 
1496.5 41066.1 
1566.5 17349.0 
1582.2 16723.6 
1608.5 19789.9 
1623.3 23770.0 
1625.6 17521.3 
1680.2 28120.0 
1751.3 16586.1 
1795.3 33883.4 
1810.9 17093.9 
1820.2 17366.4 
1836.0 16346.1 
1867.1 17900.6 
1893.1 38502.6 
1897.1 17505.7 
1911.3 30353.5 
1916.5 16768.7 
1932.8 16607.1 
1959.8 16693.9 
1963.5 17539.8 
1977.7 42189.5 
1990.1 15837.1 
1992.8 16404.3 
Alle 9_2680.88 PSD 716.7 56097.3 
831.6 18331.6 
832.9 13698.0 
833.2 15078.0 
924.4 18962.1 
928.9 14504.3 
105  
 
929.2 13522.0 
946.6 22272.2 
1100.4 13816.7 
1117.4 230272.2 
1232.8 13424.5 
1233.2 13601.3 
1233.7 13629.3 
1281.0 16774.8 
1403.3 24940.5 
1566.7 17519.0 
1660.5 17485.7 
1760.7 18647.8 
1853.8 15978.7 
1889.9 14628.6 
1896.6 18198.5 
1949.7 14653.4 
1966.2 21622.6 
2083.4 21984.7 
2140.1 24248.2 
2209.8 23425.8 
2304.0 16894.0 
2392.3 16673.4 
2508.3 42554.7 
2525.6 28282.9 
2592.0 17134.1 
Alle 10_PMF 804.26 12851456.00 
884.38 20363022.00 
1125.27 79546512.00 
1143.29 264116752.00 
1466.25 112602296.00 
1510.45 1107736448.00 
1525.39 194619088.00 
1595.54 16353916.00 
1602.37 69447544.00 
1638.39 67102232.00 
1653.36 41463744.00 
106  
 
Cyst 1_PMF 1245.73 457352.50 
1597.05 6244285.00 
1636.02 1343805.63 
1673.94 2370157.75 
1726.99 968488.25 
1748.01 10408959.00 
1830.01 3972141.75 
1869.08 2145102.75 
1885.04 1705207.88 
1929.09 24045180.00 
1945.05 4091605.50 
1963.34 730127.38 
2072.20 2472753.50 
2085.14 6837568.00 
2101.18 436480.00 
2123.28 1241460.75 
2163.24 5448736.00 
2178.39 15921827.00 
2194.33 5922394.50 
2258.29 5111597.50 
2274.33 294437.16 
2474.40 23718286.00 
2483.82 512948.38 
2489.22 94822.40 
2490.40 2592935.00 
2491.48 65584520.00 
2657.55 9419442.00 
2741.51 991648.06 
2785.64 13953695.00 
2948.67 4953807.50 
3046.86 3008956.25 
Cyst 2_PMF 784.05 21493578.00 
724.11 21493578.00 
869.20 21493578.00 
949.62 119971672.00 
1062.10 21493578.00 
107  
 
1064.18 21493578.00 
1011.53 14925413.00 
1495.57 3074646.75 
1642.60 1887645.88 
1721.70 90390224.00 
1783.62 44874984.00 
1847.50 7648141.00 
2224.81 13092320.00 
2682.04 3160209.25 
Cyst 2_950.00 PSD 46.7 3471.6 
79.5 3456.2 
117.0 8740.3 
119.0 3603.2 
119.2 4339.8 
175.7 5919.8 
300.9 8279.7 
306.8 4953.5 
328.9 3703.4 
343.5 3392.5 
346.0 3423.8 
371.8 11757.8 
416.8 3715.9 
421.9 5254.2 
493.0 6700.6 
507.0 7710.6 
533.6 3719.8 
534.9 6600.1 
536.0 3965.3 
564.3 4356.3 
605.8 7132.5 
650.3 40187.8 
652.3 16462.4 
726.5 5442.0 
732.1 6851.8 
736.5 6428.8 
744.5 5785.8 
108  
 
746.5 5393.3 
768.6 6796.9 
787.4 8561.2 
795.4 8169.0 
797.6 9734.3 
800.2 7310.9 
907.4 7370.2 
914.5 8019.3 
918.5 7427.9 
Cyst 2_1721.70 301.0 7107.3 
430.3 7467.9 
650.9 25532.8 
951.1 7480.7 
974.9 8567.6 
1037.1 7996.8 
1073.4 38945.2 
1152.2 8125.5 
1176.2 18230.6 
1193.5 32507.2 
1275.2 8197.5 
1290.6 8592.5 
1308.8 8516.6 
1477.6 13382.6 
1494.8 20582.2 
1521.0 17136.7 
1549.3 18075.1 
1567.2 69203.6 
1663.4 47790.6 
1677.7 9934.0 
1681.0 94983.1 
Cyst 3_PMF 722.22 10772750.00 
881.57 26742154.00 
949.75 422441408.00 
975.78 94209560.00 
1013.68 35654632.00 
1165.82 156552288.00 
109  
 
1227.74 18999954.00 
1342.27 12184053.00 
1642.82 5700278.50 
1721.92 14377586.00 
1926.95 115895224.00 
1990.82 8899438.00 
2152.05 196677376.00 
2170.08 60765388.00 
2213.98 20801286.00 
Cyst 4_PMF 1303.89 390235712.00 
1345.76 435525248.00 
1361.78 161775376.00 
1526.91 118757288.00 
1642.13 221640064.00 
1842.08 76772232.00 
1980.26 270720384.00 
2630.63 511556640.00 
2758.70 95051376.00 
Cyst 4_1346.41 PSD 175.5 119439.5 
186.6 92911.1 
278.6 31835.0 
299.5 119930.6 
349.5 59511.7 
357.7 54986.1 
390.4 69494.9 
407.4 101704.0 
428.5 166439.4 
478.5 51995.3 
525.6 63799.3 
542.7 110369.0 
553.6 57895.3 
570.6 83660.8 
641.9 96026.2 
688.8 68502.5 
706.1 171426.6 
760.0 57488.9 
110  
 
777.0 64440.1 
805.0 152703.8 
901.9 104615.8 
918.9 307807.5 
922.8 37448.0 
1048.2 62359.1 
1050.5 34154.1 
1162.2 60654.6 
1232.4 106150.9 
1280.7 45821.4 
1285.1 82522.7 
1300.7 94325.5 
1302.1 651647.8 
1303.4 571763.5 
1312.2 57603.0 
Cyst 4_1643.12 PSD 417.14 20000 
516.74 25646.81 
615.07 20000 
1372.40 150371.86 
1515.55 1309522.75 
1599.12 1847325.88 
Cyst 5_PMF 726.25 6092046.50 
869.07 6203945.00 
926.15 2506496.00 
927.27 2506496.00 
976.61 2237743.50 
1119.06 1146957.63 
1198.91 2506496.00 
1444.91 10576172.00 
1572.14 2863197.75 
1792.06 1778109.63 
1836.05 10310912.00 
1852.08 3631995.50 
Cyst 5_1445.08 PSD 247.32 4565.99 
398.69 31210.55 
504.31 4565.99 
111  
 
575.42 3848536.50 
673.28 48004.13 
747.27 1629.13 
973.14 286392.09 
997.72 3361.65 
1013.27 72114.90 
1029.76 236021.25 
1069.86 188187.84 
1087.12 244364.78 
1165.53 35032.08 
1226.79 316222.47 
1256.00 45481.43 
1323.44 134316.39 
1369.13 75367.59 
1402.41 5124274.00 
1428.51 6124274.00 
Cyst 5_1836.19 PSD 443.18 2450.34 
571.64 2450.34 
641.31 427709.25 
755.56 611518.06 
870.31 330914.72 
983.48 468513.34 
1082.23 274197.78 
1195.45 127142.59 
1266.55 127051.52 
1394.93 18029.78 
1804.95 245.34 
1820.30 868989.94 
Cyst 6_PMF 869.24 11271020.00 
947.57 2746316.75 
1029.66 15320890.00 
1166.71 14617464.00 
1294.70 32098466.00 
1408.63 1351597.00 
1422.75 2585857.25 
1433.70 5883975.50 
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1525.10 3643718.50 
1592.85 9949606.00 
1642.66 5469033.00 
1765.66 3362337.00 
1791.65 6928282.50 
2224.83 11294165.00 
Cyst 6_1294.81 PSD 148.5 5746.6 
160.0 5684.6 
263.1 8061.8 
303.9 7803.8 
383.0 6235.5 
402.0 7951.6 
430.2 6064.0 
432.8 6730.0 
449.3 12236.7 
467.8 5867.6 
488.8 5699.5 
591.3 6940.1 
617.5 7450.8 
634.6 6691.4 
663.1 7310.5 
701.6 6942.0 
718.4 11091.6 
735.1 6503.8 
765.5 6402.2 
842.7 7279.2 
860.9 7198.7 
873.6 7640.6 
912.7 7105.4 
970.4 7400.9 
985.8 7214.7 
989.6 7534.0 
1007.9 7746.4 
1023.4 6974.5 
1071.9 7056.6 
1080.7 6809.6 
113  
 
1114.4 8152.5 
1137.4 7463.6 
1152.2 13732.2 
1168.4 59729.9 
1230.2 17600.2 
  
Cyst 8_PMF 1078.83 31924740.00 
1147.85 22382712.00 
1320.87 5391822.50 
1412.98 11877097.00 
1596.15 36487040.00 
1603.20 3676643.00 
1643.11 6870966.00 
1860.22 94425592.00 
1892.18 13220835.00 
1918.39 14194784.00 
1944.32 4062769.50 
1988.37 185602112.00 
2011.53 136331344.00 
2020.35 76969584.00 
2062.47 2190052.50 
2071.57 7956780.50 
2116.51 41727652.00 
2148.49 8221866.00 
2163.65 64097616.00 
2167.68 16863514.00 
2273.76 6272812.50 
2519.78 2667196.25 
2625.10 22417514.00 
Cyst 8_1989.40 PSD 175.81 2409.53 
303.46 523338.53 
443.33 38016.34 
494.82 3557053.50 
606.08 202137.39 
623.13 3577897.25 
667.06 1032557.94 
114  
 
778.53 364680.44 
795.50 1253248.13 
907.07 79353.52 
1069.76 361202.41 
1093.68 132125.69 
1110.55 129916.65 
1256.32 313459.19 
1419.46 536644.75 
1520.59 1443721.25 
1547.82 491613.03 
1649.32 1590230.75 
1734.02 112252.52 
1816.55 1346224.75 
1862.53 19761382.00 
1946.94 8494557.00 
1960.25 1554906.50 
1972.84 15744160.00 
Cyst 9_PMF 977.53 13912711.00 
1039.47 877985.94 
1087.53 108416584.00 
1125.65 10706384.00 
1149.43 852092.56 
1183.63 34112552.00 
1198.68 31631.66 
1200.66 113379824.00 
1201.07 45656.94 
1204.65 22630.40 
1206.72 4632060.50 
1208.72 7375546.00 
1215.65 185270.86 
1232.62 1392369.75 
1247.55 58075660.00 
1262.59 1582534.63 
1309.50 2672937.75 
1328.78 7481869.00 
1369.69 2141485.25 
115  
 
1375.65 5559163.00 
1385.78 2692295.50 
1429.74 31927180.00 
1433.74 1176126.75 
1457.80 17263456.00 
1497.76 1008067.75 
1519.72 758065.69 
1900.89 2784412.00 
2019.90 221960.44 
2047.10 3350513.25 
2062.02 4960752.00 
2163.02 19967598.00 
2173.02 33554540.00 
2189.02 101549.40 
2205.01 97242.06 
2224.90 19191.45 
2234.95 148046.92 
2301.12 33343300.00 
2333.11 1659308.13 
2363.02 157559.81 
Cyst 9_1088.33 PSD 84.6 9219.1 
136.7 12210.3 
174.5 9112.0 
175.5 29798.8 
229.3 16293.5 
229.9 13809.5 
269.1 8642.2 
287.4 20196.5 
293.1 8827.0 
304.8 8668.4 
312.7 21549.7 
330.7 43774.7 
383.9 42482.1 
393.4 8793.6 
393.9 10698.5 
401.7 22070.7 
116  
 
428.5 8963.4 
450.7 20588.6 
467.4 8828.3 
474.2 9236.4 
507.8 22208.0 
509.1 12466.6 
524.9 19246.4 
526.1 9727.1 
536.9 11061.0 
603.8 9768.8 
613.0 11327.7 
621.8 16388.1 
645.4 8928.7 
671.2 34336.6 
688.3 21343.4 
724.0 11115.3 
741.8 11891.8 
743.4 11895.7 
759.1 23461.5 
785.0 9987.4 
788.5 11040.9 
790.9 12777.9 
792.7 9929.3 
793.7 9730.3 
802.3 10211.7 
816.2 10718.1 
818.0 10571.5 
830.1 11858.4 
839.3 10864.8 
844.0 10691.5 
848.1 12550.0 
852.2 10135.6 
856.9 12881.2 
860.1 21608.1 
923.5 27229.8 
945.3 14346.7 
117  
 
973.0 198478.8 
974.4 126593.3 
987.7 15861.7 
999.5 20096.4 
1010.2 13976.2 
1020.0 15120.0 
1029.2 106191.9 
1030.9 50699.6 
1037.4 20760.0 
1039.5 16817.5 
1044.0 80615.1 
1045.5 55752.2 
1052.9 13919.6 
1054.8 15187.4 
1061.8 49260.0 
1063.2 48909.7 
1064.5 21084.3 
Cyst 9_2302.00 PSD 746.4 15292.9 
1033.0 14637.2 
1558.8 22356.6 
1733.2 30447.1 
1845.6 14632.3 
1862.6 23852.0 
1945.1 29929.9 
1988.2 14422.8 
2015.1 13766.3 
2104.2 13808.6 
2104.7 14907.0 
2105.4 14440.5 
2106.6 14571.7 
2129.5 18079.3 
2147.0 14180.9 
2151.5 34545.7 
2155.1 14797.9 
2170.6 15957.8 
2174.4 17592.4 
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2176.5 17356.2 
2233.0 16320.9 
2235.0 15064.1 
2244.5 19168.7 
2247.4 25766.7 
Enc 2_PMF 631.55 53640972.00 
644.56 34255556.00 
666.14 15394712.00 
682.11 8417404.00 
795.58 30821296.00 
893.06 9688669.00 
923.61 20485528.00 
1132.47 41121548.00 
1444.59 38287032.00 
1487.56 14147940.00 
1515.40 132478728.00 
1790.36 161272752.00 
1953.40 8076526.50 
1960.25 24071988.00 
2182.18 12111594.00 
2310.20 68474736.00 
3164.97 74778432.00 
3372.88 8071694.00 
Enc 2_1791.43 PSD 171.8 10932.8 
175.3 12869.5 
224.5 8452.5 
250.3 11357.7 
267.4 8750.8 
285.9 13775.2 
304.1 9959.5 
341.1 9369.4 
350.3 8940.0 
368.6 13265.3 
380.1 32146.3 
398.2 34625.8 
478.4 13323.9 
119  
 
496.9 29419.3 
512.0 11372.8 
588.4 17273.9 
610.2 20151.4 
689.4 16913.4 
694.4 12271.8 
710.0 12843.4 
760.5 10812.5 
803.3 14798.5 
862.6 11000.0 
890.5 18599.3 
901.9 16260.0 
989.1 16126.7 
1009.1 11061.3 
1022.2 13081.3 
1031.8 14424.0 
1041.9 16885.0 
1086.6 231294.2 
Enc 3_PMF 930.40 6439680.00 
1086.56 9021696.00 
1197.60 9300480.00 
1433.51 7395328.00 
1487.51 71538200.00 
1549.43 17339152.00 
1643.48 28604720.00 
1706.51 11662592.00 
1775.50 9200640.00 
1813.47 8340736.00 
1960.51 84187912.00 
2023.51 8637952.00 
2116.51 18156900.00 
2224.46 12843950.00 
2301.64 16857574.00 
2336.55 17290810.00 
2371.71 32810502.00 
2430.59 8063744.00 
120  
 
2528.71 19339592.00 
2592.71 10361600.00 
Enc 5_PMF 780.58 2576442.25 
816.59 1438414.50 
893.10 1713327.00 
930.57 2227245.00 
1002.64 3163719.25 
1130.73 1467568.63 
1197.87 5380491.00 
1284.68 2983466.00 
1392.77 2519176.00 
1465.82 7334817.00 
1487.93 38970472.00 
1521.86 6535932.00 
1545.00 1125500.13 
1644.02 18408274.00 
1703.01 688260.31 
1765.94 684746.88 
1777.05 4571527.50 
1791.86 2244883.75 
1814.03 4345337.50 
1833.04 5735110.50 
1849.02 1160483.13 
1858.10 4562613.00 
1917.07 2345234.00 
1959.04 1312705.25 
1977.14 3300580.75 
1993.11 3599913.75 
2018.08 3419853.75 
2080.24 3126138.75 
2297.14 6744868.00 
2301.20 169881.59 
2384.07 4967957.50 
2430.37 5783489.00 
2455.30 1026548.00 
2534.22 1736664.25 
121  
 
2593.48 7805887.00 
 
Enc 5_1489.80 PSD 437.0 7063.8 
567.8 7721.6 
607.3 13608.9 
696.8 7412.6 
697.8 8733.1 
736.6 10943.9 
738.3 7612.7 
754.5 9177.1 
833.9 7754.2 
839.9 7200.5 
840.9 7100.6 
850.2 9528.6 
867.0 7567.8 
867.7 7229.7 
939.0 7490.6 
961.1 7792.1 
978.8 51817.2 
981.9 8210.3 
1032.6 7729.0 
1075.5 7265.9 
1093.2 8250.3 
1094.7 8025.2 
1103.3 6856.8 
1105.6 8180.9 
1110.1 7268.1 
1115.4 7108.3 
1117.6 7019.6 
1204.0 7293.0 
1207.5 7494.6 
1250.5 7469.2 
1285.1 8775.9 
Enc 6_PMF 804.53 14766314.00 
889.58 9713776.00 
998.61 20419022.00 
122  
 
1070.64 11546517.00 
1088.61 67646248.00 
1091.70 3697966.50 
1135.68 21248796.00 
1183.84 74045800.00 
1395.92 39310968.00 
1432.86 103491080.00 
1494.81 14230146.00 
1504.88 85337904.00 
1538.97 16464896.00 
1586.95 53699132.00 
1602.92 22965160.00 
1618.93 23541558.00 
1630.01 6069988.00 
1660.98 35410652.00 
1695.96 7874932.00 
1726.94 59546308.00 
1937.08 51480080.00 
2067.09 31142604.00 
2086.17 71630000.00 
2108.14 21978660.00 
2197.26 14970997.00 
2201.23 1976832.13 
2488.27 25038460.00 
2783.43 717605184.00 
3038.51 25636180.00 
Enc 6_1432.85 PSD 256.1 21633.5 
256.3 20737.5 
295.2 32063.8 
313.1 22407.6 
325.2 23378.5 
382.2 31750.8 
400.3 22411.3 
412.3 25557.2 
432.2 21688.3 
441.5 123500.2 
123  
 
458.7 139293.3 
514.4 23156.5 
522.4 31452.3 
523.6 21683.3 
531.6 42719.1 
541.5 30136.6 
550.4 24942.2 
555.3 26757.3 
559.4 37582.1 
572.4 22895.7 
580.4 65322.2 
589.3 20740.7 
597.4 31081.9 
607.4 36140.9 
614.5 46294.7 
635.7 21195.3 
678.9 30823.9 
706.9 46846.2 
710.8 25555.0 
720.6 24200.8 
727.7 33050.7 
774.8 21020.0 
791.8 20412.4 
802.7 33457.2 
819.7 22036.4 
831.9 20710.0 
832.9 28126.3 
859.6 36296.0 
874.8 37818.1 
931.4 39481.7 
948.5 73173.9 
959.5 28414.5 
975.6 272725.9 
977.0 171190.6 
994.3 40219.1 
1005.2 34569.9 
124  
 
1021.7 44617.3 
1023.1 35804.0 
1031.6 29992.9 
1055.9 28577.6 
1074.4 35605.9 
1089.7 37553.5 
1091.5 35762.4 
1102.9 34895.6 
1108.7 33174.9 
1120.7 29939.3 
1122.4 31571.7 
1148.9 107038.6 
1230.8 249509.0 
1232.6 282209.1 
1258.9 936599.2 
1260.2 826466.3 
1261.5 400452.3 
1276.9 4845679.5 
1278.2 4304237.0 
1279.5 2046824.8 
1291.1 65067.2 
1293.2 73076.7 
1372.9 1035421.3 
1374.2 1120788.0 
1375.5 628353.3 
1388.8 100381.1 
1390.8 3354162.5 
1392.2 2875412.5 
1393.5 1314908.6 
1399.2 159361.6 
1402.8 153040.6 
Enc 6_1505.74 PSD 175.5 45557.5 
176.3 21383.2 
326.4 38806.7 
327.5 21387.3 
420.3 20855.0 
125  
 
420.6 23686.7 
437.4 28492.6 
455.6 51783.8 
569.8 31720.1 
608.0 126736.5 
699.0 57097.4 
737.9 47043.8 
756.3 76261.7 
834.1 48716.7 
840.9 28908.7 
842.0 28783.3 
851.5 114546.3 
869.3 41260.6 
938.9 22118.6 
956.0 21388.1 
979.8 451288.7 
981.1 308150.2 
1031.8 28262.5 
1033.2 26328.1 
1069.1 20642.9 
1078.3 39352.0 
1095.4 47228.6 
1141.4 20492.9 
1150.0 21530.1 
1209.6 24285.7 
1215.0 23628.3 
1263.3 22808.2 
1264.4 22450.4 
1274.7 22657.5 
1288.7 42915.6 
1290.8 22441.1 
1306.1 105595.6 
1309.1 22894.2 
1339.6 28695.9 
1391.9 23914.7 
1392.6 23765.7 
126  
 
1393.4 23495.2 
1395.2 23552.7 
1418.5 38215.9 
1432.3 85181.4 
1450.5 47064.4 
1454.6 37473.1 
1461.1 39333.1 
1463.4 37597.7 
Enc 6_2087.20 627.9 39761.6 
644.1 36012.5 
742.1 61866.7 
840.6 55638.0 
856.4 27477.4 
857.5 23442.5 
859.1 22949.1 
860.3 23080.7 
968.9 46511.8 
985.5 21549.5 
986.6 22355.2 
1052.4 44644.6 
1070.3 32381.5 
1115.1 38611.0 
1151.4 40835.4 
1169.3 25356.1 
1232.4 45153.7 
1319.2 29006.3 
1329.3 23305.2 
1346.8 50931.4 
1445.77 43319.9 
1464.7 25105.2 
1466.7 27257.9 
1483.9 217160.0 
1573.8 29488.2 
1597.2 38764.9 
1657.5 34838.3 
1675.0 37667.5 
127  
 
1756.5 34933.2 
1759.8 30708.2 
1774.1 27289.3 
1775.9 23568.4 
1888.7 49125.3 
2027.0 20565.2 
Enc 8_PMF 659.29 13629466.00 
795.47 205284768.00 
821.51 4623886.00 
827.11 8310182.00 
847.97 1988712.50 
857.41 4436958.00 
858.91 0.00 
859.02 96768.00 
859.43 3871481.25 
859.77 23296.00 
923.58 166748272.00 
948.47 11659561.00 
985.52 6777086.50 
1086.66 180455856.00 
1175.68 147395536.00 
1230.72 16891984.00 
1232.10 254301.09 
1232.72 10301819.00 
1272.78 14906127.00 
1444.90 18149550.00 
1460.90 8685528.00 
1790.97 172467152.00 
1833.11 14352985.00 
1850.11 4837197.50 
1917.83 4021352.00 
Enc 8_1173.66 PSD 505.8 25623.0 
540.0 18049.0 
540.1 17059.3 
540.6 20424.4 
564.2 24440.6 
128  
 
564.7 21893.0 
565.6 18261.9 
597.8 18569.0 
598.2 16979.0 
598.7 21795.3 
600.0 28083.1 
620.6 36565.1 
634.1 30985.1 
644.4 17373.1 
645.2 28717.2 
677.9 19121.6 
678.9 20391.3 
679.6 29537.9 
691.7 17536.8 
693.5 46612.1 
724.3 96313.1 
776.8 20493.4 
830.3 18579.2 
830.7 20561.6 
831.9 27952.0 
850.4 20479.5 
853.6 21177.5 
854.2 18246.1 
860.4 42452.6 
866.8 18551.0 
867.9 24145.2 
872.1 41169.4 
885.3 74829.9 
901.1 17578.8 
901.9 18638.7 
902.7 20292.6 
908.7 22128.0 
916.7 31948.4 
921.0 20082.5 
922.2 25669.9 
936.0 316326.8 
129  
 
949.2 156418.2 
970.6 43319.2 
983.6 22032.2 
984.4 22049.3 
990.4 38856.8 
1003.7 56670.8 
1017.2 20720.0 
1074.4 106554.9 
1088.3 26046.5 
1090.3 24527.9 
1095.7 48026.0 
1097.9 20910.2 
1109.1 189624.0 
1118.9 21609.4 
1128.1 63360.4 
1138.5 23569.0 
1139.7 29765.4 
1141.0 31243.9 
1147.6 22326.0 
Enc 9_PMF 841.57 847143.88 
1034.56 2096352.50 
1055.50 14441655.00 
1072.52 10529026.00 
1098.55 900966.88 
1117.42 706880.25 
1143.53 762435.25 
1162.63 2483855.25 
1200.59 7249820.00 
1275.69 3685102.25 
1371.57 3764028.50 
1403.77 2227969.00 
1499.73 3008522.25 
1516.73 1955654.75 
1531.73 11205929.00 
1620.81 2591312.75 
1689.76 1684591.00 
130  
 
1748.88 3559473.25 
1917.88 23406368.00 
2070.95 13174273.00 
2314.05 7365880.50 
2344.06 7094515.00 
2378.96 1000.000 
2442.14 7925356.50 
2571.16 26734146.00 
Enc 9_1052.69 PSD 111.3 7233.8 
112.2 3912.1 
159.0 3962.1 
176.2 26597.2 
253.9 7279.8 
259.2 7310.5 
296.2 24554.3 
313.4 287813.2 
368.2 5108.9 
388.5 41161.2 
393.5 5292.5 
411.4 32667.1 
428.4 11662.7 
517.7 29944.4 
524.5 10763.9 
534.6 6313.5 
541.8 22684.4 
604.5 6936.8 
617.4 6467.6 
623.5 5950.3 
653.6 9784.7 
655.0 8937.4 
670.8 11582.2 
755.1 9114.9 
765.2 9171.9 
782.3 8904.8 
798.4 11558.5 
801.2 9263.0 
131  
 
855.2 11762.5 
883.6 12970.6 
901.0 28857.3 
928.1 9460.5 
998.9 16803.2 
1013.7 23529.1 
1016.7 18129.2 
1023.8 19213.7 
Enc 10_PMF 912.51 4143515.00 
1055.47 2480529.75 
1159.59 2936832.00 
1176.61 10149103.00 
1341.55 58495572.00 
1602.69 99445984.00 
1685.68 40012848.00 
1698.81 18919548.00 
1760.72 1000 
1905.56 1000 
1995.61 1000 
1730.77 6766083.50 
1841.64 6666534.50 
1917.74 8678654.00 
1956.84 8618480.00 
2061.70 65446700.00 
2104.75 7795500.50 
2125.06 698045.69 
2151.69 8175161.50 
2162.81 1000000.00 
2208.70 2926180.25 
2224.70 4079467.2 
Enc 11_PMF 912.70 7046144.00 
1159.91 9953536.00 
1176.92 18571392.00 
1300.83 602368.00 
1308.01 1385472.00 
1329.05 247552.00 
132  
 
1341.93 10985984.00 
1403.02 2807040.00 
1455.07 1258752.00 
1476.12 4118411.75 
1538.06 1756928.00 
1603.22 47945728.00 
1712.25 4474414.50 
1843.23 26001920.00 
1843.56 80416.00 
1971.32 1967587.50 
2006.29 1656320.00 
2018.31 3483776.00 
2063.30 97184512.00 
2105.39 7504384.00 
2106.43 10316928.00 
2120.38 5527040.00 
2163.41 3387392.00 
2274.49 1881344.00 
2324.47 1116416.00 
2384.31 3075328.00 
2479.62 52626.29 
2501.54 2171155.75 
2551.55 373248.00 
2751.68 8197888.00 
2768.76 1003392.00 
Enc 11_1603.30 271.4 6870.9 
272.1 8665.1 
431.8 7485.6 
467.8 6863.0 
558.8 7069.8 
560.1 8301.7 
631.6 8579.8 
657.7 7770.5 
659.5 9480.5 
660.8 6517.3 
674.5 8236.9 
133  
 
675.8 7023.6 
771.2 6461.5 
930.6 35979.9 
991.7 7617.1 
1002.6 7097.0 
1017.9 6483.4 
1039.1 7369.7 
1058.9 6732.4 
1060.4 8037.8 
1069.1 6496.9 
1074.4 6852.1 
1122.9 7027.8 
1127.8 6421.5 
1141.4 6532.9 
1195.8 6554.8 
1208.1 6520.2 
1231.4 9663.6 
1245.0 7078.3 
1259.9 6515.4 
1268.3 7017.3 
1288.6 6922.4 
1330.7 8446.8 
1333.0 8778.7 
1348.3 6840.8 
1404.0 6597.9 
1431.0 7061.8 
1434.5 6710.0 
1465.1 7307.2 
1467.0 6842.4 
1470.0 7659.4 
1500.6 7278.7 
1504.1 7038.0 
1519.8 13913.9 
1524.9 6960.5 
1535.5 9716.7 
1536.7 6965.3 
134  
 
1537.2 6804.7 
1548.7 8169.4 
1560.5 58112.8 
Enc 11_1688.73 PSD 276.7 15583.0 
325.6 16097.9 
342.7 19873.0 
424.0 32053.5 
441.1 11017.4 
442.2 13168.5 
538.0 10661.8 
538.7 13383.9 
539.7 10549.1 
556.8 10865.5 
593.1 10530.6 
643.7 12058.5 
752.6 11123.9 
915.7 11104.1 
916.3 10233.6 
933.4 11802.3 
935.2 13858.5 
1043.5 10189.9 
1062.5 11329.4 
1063.3 10831.8 
1064.4 11768.9 
1115.0 10220.8 
1132.5 11261.4 
1150.4 13881.6 
1245.3 10207.5 
1264.7 10686.0 
1346.0 11279.4 
1409.2 10337.9 
1411.0 10454.5 
1411.8 11189.0 
1550.6 10717.0 
1554.8 10231.8 
1572.4 10686.4 
135  
 
1599.8 41664.1 
1625.0 10483.4 
1628.0 15756.4 
1639.0 26256.1 
1643.5 14739.5 
1645.3 12640.0 
Enc 11_2065.03 PSD 287.7 18065.5 
352.5 9547.5 
353.9 17370.4 
542.1 11653.5 
827.9 19710.6 
880.9 13112.9 
896.3 21404.2 
926.2 9992.9 
942.4 26573.3 
1152.5 9700.1 
1168.8 33703.2 
1218.5 9278.4 
1235.5 14722.2 
1279.8 11605.0 
1297.2 17519.9 
1299.3 9349.3 
1396.9 10724.4 
1425.2 10418.1 
1470.9 9246.9 
1503.2 10046.0 
1505.6 14604.6 
1522.6 48740.7 
1555.0 9574.5 
1559.5 10844.5 
1579.0 9581.3 
1607.1 10861.2 
1609.0 9649.1 
1623.9 14036.0 
1680.6 17971.5 
1732.9 10270.7 
136  
 
1759.7 13027.1 
1777.1 81911.0 
1808.0 10005.4 
1810.3 11983.7 
1825.1 10684.8 
1828.3 15594.8 
1857.7 10764.8 
1863.6 10857.0 
1868.6 10306.7 
1890.2 15842.9 
1908.3 20212.4 
1927.4 17727.4 
1944.7 10265.5 
1956.8 11380.2 
1973.6 47045.3 
1986.7 12292.6 
2003.8 31628.8 
2020.4 195293.2 
Tropho 1_PMF 869.12 4269824.00 
944.66 6654805.00 
1068.51 7015799.50 
1175.62 1517476.38 
1284.82 26326968.00 
1385.78 18241762.00 
1447.69 9004502.00 
1544.90 12367838.00 
1589.82 4599519.00 
1603.83 4527624.00 
1623.78 5746077.50 
1628.86 10043498.00 
1685.72 3693897.00 
1690.82 6286702.00 
1700.96 19305380.00 
1762.93 10659343.00 
1824.84 3976013.25 
1950.91 8183350.00 
137  
 
2012.83 5160865.50 
2123.02 9524162.00 
2137.02 8363952.50 
2210.04 16630027.00 
2224.05 14497779.00 
2398.11 3679620.00 
2632.45 4538630.00 
Tropho 2_PMF 746.13 3733534.25 
1093.58 8630730.00 
1325.63 1435646.63 
1791.81 2173103.00 
1873.02 7573207.00 
2111.10 16285560.00 
2163.09 5651420.00 
2239.25 62875164.00 
2304.13 1341417.75 
2812.36 2163126.75 
2911.42 2248791.50 
2925.47 5147336.50 
2952.39 14275670.00 
3014.26 1946369.75 
3056.26 2580529.25 
3068.58 0.00 
3152.41 411197.56 
3182.57 1224690.63 
3195.58 19248366.00 
3234.68 347037.16 
3300.67 11754.67 
Tropho 2_2111.10 PSD 1042.3 8194.8 
1042.8 8697.3 
1566.2 18500.6 
1655.4 31528.6 
1681.3 33133.0 
1883.3 9058.2 
1981.9 10700.1 
1983.4 9193.3 
138  
 
2000.0 29801.8 
2017.2 8351.3 
Tropho 2_2239.25 PSD 713.61  8904.7 
827.6 8059.1 
1030.9 8402.6 
1039.6 9078.0 
1066.4 12941.5 
1083.8 13553.2 
1125.6 8591.4 
1140.7 10606.8 
1167.3 7985.3 
1183.4 17282.2 
1210.8 10571.0 
1223.2 9177.8 
1297.5 9653.2 
1378.5 8333.9 
1413.0 8948.4 
1436.8 8319.3 
1541.2 9278.4 
1578.1 8491.8 
1595.96 16091.0 
1637.484121 10515.2 
1655.0 77876.9 
1694.2 46132.3 
1711.2 16751.8 
1713.7 8652.0 
1736.3 13387.1 
1752.8 10880.4 
1754.6 8844.7 
1758.8 8717.1 
1767.3 9225.3 
1769.6 11277.3 
1790.9 9880.6 
1809.3 79099.9 
1851.1 8676.0 
1914.2 9144.6 
139  
 
1967.8 13957.7 
1970.8 9569.9 
1980.7 8722.9 
2012.3 18206.8 
2024.9 9147.5 
2082.5 12500.2 
2110.6 31053.5 
2114.7 9328.8 
2123.8 9141.5 
2127.7 89230.4 
2150.2 9107.3 
2168.9 11158.4 
2177.2 13283.3 
2180.6 10747.3 
Tropho 5_PMF 1404.88 80877456.00 
1465.95 15292626.00 
1483.84 496359.84 
1490.88 2638800.75 
1664.89 1469183.00 
1681.92 3031653.50 
1707.88 22272.00 
1765.91 5458652.50 
1783.95 260527120.00 
1809.95 305725312.00 
1835.99 19758994.00 
1845.87 16222680.00 
1866.01 4251439.50 
1871.88 7248123.00 
1961.07 12593992.00 
2156.10 161396448.00 
2182.12 159149216.00 
2218.03 11018420.00 
2244.04 11619456.00 
2258.13 50924380.00 
2273.22 671149.19 
2281.02 616607.50 
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2292.19 788708.50 
2384.04 6468378.00 
3118.46 5316452.50 
3162.54 95719416.00 
3224.51 3049469.50 
E-actin_PMF 945.71 2878494.00 
976.61 3687019.50 
1197.85 261632.00 
1198.87 21104024.00 
1259.78 225024.00 
1515.89 6040323.50 
1777.01 226685824.00 
1960.08 18243762.00 
1972.22 6801426.50 
1976.07 4587337.00 
1981.94 1262398.63 
2228.31 2990312.25 
E-actin_1776.88 PSD 175.1 64964.1 
251.1 34015.3 
286.1 51698.2 
304.1 42640.6 
380.1 211601.5 
400.1 218583.0 
574.2 64811.3 
581.3 37446.7 
675.3 86334.2 
693.3 62076.6 
711.3 47741.0 
771.3 37207.0 
788.4 76001.0 
887.4 48542.4 
890.3 89931.7 
971.4 32843.7 
989.4 80211.5 
1015.5 44235.8 
1055.5 49975.0 
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1072.5 1679289.0 
1169.5 84556.4 
1186.5 53498.6 
1203.5 33369.5 
1222.7 33935.6 
1239.5 34478.5 
1240.5 50743.0 
1266.6 42601.3 
1284.6 178905.0 
1359.6 35663.2 
1397.7 257588.5 
1689.8 459851.0 
 
